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Abstract
Introduction:
Adults with Attention Deficit Hyperactivity Disorder (ADHD) vary widely in their symptom
presentation and functional deficits, which can make management in the primary care setting
challenging for providers (Morstedt, Corbisiero, Bitto, & Stieglitz, 2015). Measurement-based
care is common in the management of medical disease, however is rarely used as standard
practice in treatment of psychiatric disorders (Waldrop & McGuinness, 2017). As a result,
treatment for psychiatric conditions, such as ADHD, may vary widely among clinicians and may
result suboptimal treatment and patient outcomes (Waldrop & McGuinness, 2017). The proposed
solution was to introduce the use of a standardized measurement tool for evaluating ADHD
symptoms in the primary care setting. The purpose of this project was to implement an ADHD
tool kit and a validated ADHD symptom scale and evaluate clinical practices surrounding the
assessment and treatment of ADHD.
Objectives:
The goal of this quality improvement project was to increase the frequency that providers use a
validated ADHD symptom scale in the treatment and diagnosis of ADHD in primary care. The
project objectives were:
1.   To increase the use of ADHD assessment and symptom scales by providers within a
primary care clinic.
2.   To assess provider knowledge and clinical practices with the diagnosis, treatment, and
management of ADHD.
3.   To assess provider practices of medication prescription for the treatment of ADHD.
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4.   To assess whether use of ADHD symptom scale and toolkit increases adherence to
evidence-based practices of managing ADHD.
Methods:
For this quality improvement project, data collection occurred primarily through retrospective
record review and a provider survey before and after the intervention implementation. The
setting was an urban family practice primary care office. The primary subjects of this quality
improvement project were the providers in this office treating adult patients with ADHD.  
Results:
This quality improvement project demonstrated an increased use of ADHD symptom scales.
Secondary outcomes, such as changes in provider practices surrounding the treatment of adults
with ADHD, were not significant in the five-week implementation of this project.
Conclusions:
Through this quality improvement project, the implementation of an ADHD symptom scale and
toolkit in the primary care setting was completed. The use of the ADHD symptom scale
increased dramatically from no use to 51% uptake in the five-week project period. Despite the
great increase in use, there were no other significant changes in outcome measurements for this
project. The benefits of measurement-based care are best seen over a greater time period with
repeated measurements. Continued improvements in the care of adult ADHD patients in the
primary care setting are needed.
Implications:
Through the use of an ADHD symptom scale, providers now have the ability to objectively
measure core ADHD symptomology which should change care delivery to adults with ADHD.
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Adult Attention Deficit/Hyperactivity Disorder Quality Improvement Project: Proposal Defense
Introduction
Attention Deficit/Hyperactivity Disorder (ADHD) is one of the most common disorders
of childhood that often continues to persist into adulthood (VanCleave & Leslie, 2008).
According to the Diagnostic and Statistical Manual of Mental Disorders, fifth edition (DSM-5)
by the American Psychiatric Association (APA) (2013), ADHD is diagnosed by a “persistent
pattern of inattention and/or hyperactivity-impulsivity that interferes with functioning or
development” (p. 59). The prevalence rate of ADHD is between 1% and 7% worldwide, with
many individuals also suffering from comorbid mood, anxiety, substance use, and personality
disorders (Morstedt et al., 2015). These symptoms often lead individuals with ADHD to have
functional limitations in their daily activities which often affect their education, family and social
life, and workplace function (Morstedt et al., 2015). These deficits lead to long-term problems
and decreased function of people with ADHD and their families (Morstedt et al., 2015).
ADHD is often a lifelong condition which should be approached in the primary care
setting, similarly to other chronic conditions, to improve outcomes (VanCleave & Leslie, 2008).
Primary care providers often do not have sufficient knowledge regarding ADHD and are not
comfortable with the treatment of patients with ADHD (Ghanizadeh & Zarei, 2010). The use of
measurement-based care for the treatment of psychiatric disorders utilizes patient-reported rating
scales and allows the provider to track patients’ progress and develop a plan of care (Waldrop &
McGuinness, 2017). Measurement-based care is common in the management of medical disease,
however it is rarely used as standard practice in treatment of psychiatric disorders (Waldrop &
McGuinness, 2017). As a result, treatment for psychiatric conditions, such as ADHD, may vary
widely among clinicians and may result suboptimal treatment and patient outcomes (Waldrop &
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McGuinness, 2017). The purpose of this paper is to describe a quality improvement project
designed to evaluate ADHD management in the primary care setting through the implementation
of an evidenced-based ADHD symptom scale and ADHD tool kit for provider use.
Assessment of the Organization
The Burke and Litwin (1992) Causal Model of Organizational Performance and Change
and strengths, weakness, opportunities, threats (SWOT) analysis was used to complete the
organizational assessment. The Causal Model of Organizational Performance and Change was
designed to assess an organization for function and change. The model suggests a significant link
between effective change and organizational performance. The model asserts that change within
an organization occurs within two major dynamics; transformational and transactional variables.
Transformational variables can both affect and be affected by environmental factors such as
external environment, mission and strategy, leadership, organizational culture, and individual
and organizational performance. Transactional factors are those which affect the individual
within the organization and include structure, management practices, systems, work unit climate,
individual skills, motivation, individual needs and values, and individual and organizational
performance (Burke & Litwin, 1992).
Both transformational and transactional factors in the Burke-Litwin Model are arranged
in an open model to demonstrate significant interplay among the factors which affect
organizational performance and change (Appendix A). The model origins began in the 1960s
with the concepts of climate and culture (Burke & Litwin, 1992). Climate reflects the personal
aspects of an organization such as member’s perception of their organization; however, culture
reflects the foundation of the organization in terms of values and beliefs (Burke & Litwin, 1992).
The transformational and transactional factors reflect the interplay between the organizational
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leadership and management respectively. The Burke and Litwin (1992) model created a
framework which was utilized for the structure of a personal interview with the office manager
for assessing both the organization and the office setting. Additionally, observation through a
shadowing experience was used to understand work flow of the primary care setting and further
assess the areas of the Burke and Litwin model. Organizational data on the current ADHD
practices was obtained through chart review.
A report was generated by the office manager of all adult (18 years and older) patients
seen in the office within the last three months with an ICD-10 code for ADHD. This report was
organized by age and yielded 238 unique patients. A chart review was completed for every
seventh patient to evaluate current practices surrounding ADHD care in this office. The results
showed that as many as 35% of these patients did not have any ADHD symptoms recorded in the
history of present illness. When shadowing pediatric providers, the Conner’s Parent and Teacher
Rating Scales were observed to be routinely used to evaluate and document ADHD symptoms in
pediatric patients (Conners, Erhardt, & Sparrow, n.d.). However, no screening or measurement
tool was used in the adult population with ADHD in this office. Among providers for adults with
ADHD, there was inconsistency in evaluation, documentation, and prescriptive practices. The
electronic medical record has a template for “Adult ADHD” symptoms, but the template does
not provide a usable scale and is not consistently used in practice. Through a personal interview
with a provider in the office, management of ADHD in adults is largely “gestalt.” Gestalt implies
that clinical decisions are often made in the absence of complete information (Cook, 2009).
Through the completion of the organizational assessment, the need for improved methods of
assessment, diagnosis, and treatment of ADHD was apparent. Providers did not have the
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appropriate tools and knowledge to manage adult ADHD well in the primary care setting, which
left an opportunity for improvement in care.
Ethics and Protection of Human Subjects
The details of this project were submitted to the hospital system and Grand Valley State
University (GVSU) Institutional Review Board and deemed to be not research before the project
implementation and data collection began. The purpose of the project was limited to evidencebased intervention implementation and quality improvement in the care of ADHD patients in the
primary care setting. Physical, social, psychological, legal, and economic threats to patients were
not anticipated with this project, therefore risk to participants was considered minimal. This
quality improvement project is aimed at improving the assessment process of ADHD care by
providers in the primary care setting by implementing an evidence-based symptom assessment
scale. As with other measurement scales commonly used in primary care settings, as well as any
treatment, patients and/or providers may decline or refuse to complete the scale at any time. A
letter explaining the project details and an invitation to participate was given to providers within
the office. Completion of the survey implied consent to participate in the quality improvement
project. The risks were minimal to provider participants.
For the completion of this project, patient records were identified by having a report
generated through the electronic medical record by diagnosis code and date of visit. Protected
health information was accessed by the Doctor of Nursing Practice (DNP) student within the
organizational site using a systematic method. Data collection occurred only on the project site
location. Personal identifiers were not collected. Data was de-identified and coded into numeric
data and documented in the project database. Data was only to be accessed by the DNP student
and project team members including the site mentor, GVSU faculty advisors, and GVSU
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statisticians assisting with project. All files maintained for this quality improvement project were
password protected and can be provided to the organization at any time, including at the
conclusion of the student-led project. Analysis and the final disposition of the data is reported in
statistical terms and descriptive statistics only. Publication or dissemination of results is in
descriptive terms only, the name and location of the organization will not be identified. The DNP
student has completed human subjects training and Health Insurance Portability and
Accountability Act (HIPAA) training via the Collaborative Institute Training Initiative; and
project design reflected these principles.
Stakeholders
Key stakeholders are individuals who will either be directly affected by the project
implementation or who may have a vested interest in the outcomes of the project (Moran,
Burson, & Conrad, 2017). Stakeholders for this project included providers and staff at the
primary care practice, organizational leaders who monitor quality improvement, and patients
with ADHD. Providers and staff members were key stakeholders because their participation was
necessary to make practice change. Patients were key stakeholders because outcomes may affect
their experience and course of treatment. Lastly, organizational leaders were important
stakeholders because their support was necessary for project approval which could result in
lasting changes within the organization.
SWOT
A strengths, weaknesses, opportunities, and threats (SWOT) analysis is an assessment
tool used to evaluate an organization, program, project, or process (Moran et al., 2017). The
SWOT analysis was imperative for a thorough evaluation of the current state of evaluation and
treatment practices of ADHD in the primary care setting. The SWOT analysis was utilized to
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guide decisions for successful implementation of the change. The SWOT analysis for this
organization was summarized in Appendix B.
Strengths. Strengths of this project included a practice site which was recently utilized as
a pilot site for the recent practice change with opioid controlled substances. Similarly, the recent
law changes in the State of Michigan implicated the need for practice change surrounding
stimulant medications, so this may increase provider and staff support to the intervention.
Completion of the project provided opportunities for improved documentation of ADHD
symptoms and a more comprehensive plan of care. Improving documentation provided an
opportunity for standardized care and collaboration between providers. The team-based
environment provided needed support to the project implementation. Lastly, the Adults ADHD
Symptom Checklist (ASRS-v1.1) is freely available for use and is a valid tool (National
Comorbidity Survey, n.d.; Kessler et al., 2005).
Weaknesses. No standardized practice for the diagnosis and treatment of ADHD across
the primary care settings existed in this healthcare organization. Documentation of ADHD
symptoms was not simple or standard in the documentation system. Another weakness was that
the Centers for Medicare and Medicaid Services (CMS) currently does not have a quality
measure for ADHD care in adults, which may limit financial opportunity for reimbursement.
Adherence to an evidence-based standard of care for ADHD could increase frequency of patient
visits, which could cause scheduling difficulties in this setting. Patients may have limited access
to recommended adjunctive treatments for ADHD such as cognitive behavioral therapy.
Opportunities. With the successful implementation of this project, there was an
opportunity to improve quality of care for patients with ADHD. Patients with ADHD could be
monitored more closely for symptoms and which may result in improved patient-provider
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relationships and patient satisfaction. The project implementation plan may improve provider
knowledge and comfort with the diagnosis and treatment of ADHD. This project may improve
access to treatment for mental health. The healthcare organization may have improved
reimbursement for the CMS quality measure for ADHD care in children. Project implementation
may improve ADHD symptom documentation and quality of care for adults with ADHD.
Threats. There were several threats to the success of this project. The most detrimental
threat would have been a lack of support from key stakeholders, including organizational leaders
and office staff. Without investment from stakeholders, a significant threat would exist to the
success and sustainability of the intervention. Another threat could have been limited funding
opportunities for the necessary steps to initiate new work flow patterns with patients with
ADHD. Lastly, this office workflow was designed whereas actions that impact quality
improvement measures reside within the responsibility of the medical assistants. Staff could have
been overwhelmed with additional work that was associated with the practice change.
Clinical Practice Question
Providers in this primary care office did not have access to a validated symptom scale to
use in assessing adults with ADHD. ADHD is considered a chronic condition, as such it should
be routinely monitored with a validated measurement tool (American Academy of Pediatrics,
2011). The goal of this quality improvement project was to increase the frequency that providers
used a validated ADHD symptom scale in the treatment and diagnosis of ADHD in primary care.
The clinical practice question to be addressed was: Does implementation of an ADHD tool kit
and a validated ADHD symptom scale affect clinical practice surrounding the assessment and
treatment of ADHD?
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The outcome deliverables for the completion of this project were:
•   Implement an intervention to improve the assessment, diagnosis, treatment, and
documentation of ADHD
•   Develop a provider toolkit for the assessment, diagnosis, and treatment of ADHD. The
toolkit will include the Adult ADHD Self-Report Scale (ASRS-v1.1) Symptom Checklist,
a Quick Education Poster, an ADHD Screening Education Packet, and a letter to explain
the project.
•   Provide resources to providers to improve care of adults with ADHD in the primary care
setting.
Review of the Literature
Method
The Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA)
guideline served as the framework for this review (Moher, Liberati, Tetzlaff, Altman, &
PRISMA Group, 2009). A comprehensive electronic search was conducted in the CINAHL,
PubMed, and PsychINFO electronic data bases and was limited to peer reviewed journal articles
in the English language during the period of 2013 to 2018. Keywords were Attention Deficit
Hyperactivity Disorder or ADHD, diagnosis and treatment, quality improvement, collaborative
care, primary care, and management. Results were further limited to adults aged 18 or older with
the major subject heading of Attention Deficit Hyperactivity Disorder.
The search was limited by inclusion and exclusion criteria. Studies were included if they
focused on quality improvement, primary care, guideline adherence, measurement tools, and
intervention studies in adults with ADHD. In addition, only randomized control trials,
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systematic reviews, and meta-analyses were included. Since the focus of this literature review
was on quality improvement of adults with ADHD in the primary care setting, studies which
focused on ADHD in special populations such as children, veterans and military personnel,
student athletes, and people in correctional facilities were excluded. Additionally, studies which
focused on ADHD pathophysiology, correlational risk studies, medication trials, ADHD
prevalence studies, study protocols, and pilot studies were excluded. Studies on ADHD and
coexisting conditions such as sleep disturbances, autism, substance use disorders, and other
somatic and psychological disorders were excluded. Finally, care models for ADHD were
excluded.
PRISMA
The search yielded 868 records. Duplicates were then removed, leaving 769 records
remaining. Each review was screened using inclusion and exclusion criteria according to
PRISMA criteria (Moher et al., 2009). Each record was screened for relevance by reviewing the
title which excluded 427 records, with 342 records remaining for abstract review. Using this
inclusion and exclusion criteria, 57 total records were retained from the search and full text
records were obtained for 53 of the records. The final 53 records were evaluated in-depth for
inclusion and exclusion criteria and relevance for intervention in the adult primary care setting.
Using the inclusion and exclusion criteria, the records were narrowed to 22 studies included in
this review (Appendix C).
Summary of Results
This literature review was helpful in determining potential directions for intervention in
the treatment and care of adults with ADHD in the primary care setting. This literature review
highlighted several clinical guidelines that appeared to be well respected in ADHD care. The
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most commonly cited clinical guideline in this literature review was the National Institute for
Health and Care Excellence [NICE] guideline for ADHD care from the United Kingdom (NICE,
2018). Other clinical guidelines for the treatment of adult ADHD were the British Association of
Psychopharmacology (2007), European Network Adult ADHD (2010), Canadian Attention
Deficit Hyperactivity Disorder Resource Alliance (2010), and National Institute of Mental
Health (2008) (Rabito-Alcon & Correas-Lauffer, 2014). These guidelines had a consensus that
diagnosis of ADHD should be made by clinical assessment; pharmacological intervention was
considered first-line therapy; and pharmacotherapy should be complemented with psychosocial
interventions (Rabito-Alcon & Correas-Lauffer, 2014).
Psychosocial interventions that were highlighted in the literature review appeared to be a
helpful adjunctive treatment to first line pharmacological therapy; however, they appeared to be
significantly underutilized in practice. Cognitive behavioral therapy seemed to be the most well
supported in ADHD care, with improvement in self-reported ADHD symptoms (Lopez et al.,
2018). Cognitive behavioral therapy had been shown to be efficacious in medication-treated
adults with ADHD (Young et al., 2015). Another study, Hirvikoski et al. (2017) evaluated
psychoeducation for adults with ADHD and their significant others and demonstrated
effectiveness of this intervention over treatment as usual in global life satisfaction and treatment
satisfaction.
Two studies in this literature review evaluated long-term outcomes in patients with
ADHD. Arnold et al. (2015) utilized a systemic review to evaluate 403 primary studies reporting
long-term outcomes greater than two years for patients with ADHD which found that highest
proportion of improved outcomes was with combination of pharmacological and
nonpharmacological treatments. Swanson et al. (2017) followed 515 children into adulthood to
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evaluate symptom severity, height, treatment, and long term use of stimulants. Half of the
children had ADHD and half were in a normative comparison group (Swanson et al., 2017).
Extended use of medications was associated with reduction in symptom severity and suppression
of adult height (Swanson et al., 2017). Study results indicate the possibility of low dose
psychosocial treatment with lower medication dosing may preserve efficacy of results and longterm growth (Swanson et al., 2017).
Assessment tools were important for measuring symptom severity and functioning
because adults with ADHD because of the variety of impairments among adults. Both executive
functioning and non-executive functioning testing were found to be important in identifying
persons with ADHD (Kamradt, Ullsperger, & Nikolas, 2014). Morstedt et al. (2015) evaluated
the agreement between self and informant rating on symptoms and functional impairment. Selfrating was more similar to clinical ADHD diagnosis than informant rating. Adults with ADHD
were less likely than the informants to identify functional impairments as a result of their
symptoms. This study found that both the patients with ADHD and their relatives are important
sources of information for assessment of symptoms and functional impairment (Morstedt et al.,
2015). The World Health Organization [WHO] Adult Attention-Deficit/Hyperactivity Disorder
Self-Report Screening Scale for DSM-5 was developed to screen for patients who meet the
DSM-5 diagnostic criteria of ADHD (Ustun et al., 2017). The WHO ADHD Self Report
Screening Scale for DSM-5 was found to have high specificity and positive predictive value for
adults with ADHD in the general population (Ustun et al., 2017).
One major limitation of this literature review was that medication efficacy trials were not
included because medications are considered first line therapy for ADHD. However, medication
therapy is a mainstay of treatment for ADHD in the primary care setting, so not including these
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studies may have weakened the literature review. Lastly, the purpose of the literature review was
to gather information broadly, so specific interventions were not focused on which could be a
limitation.
Evidence to be used for Project
The results of this literature review provided focus and support for possible areas of
intervention in the primary care setting in the treatment of ADHD patients. Potential
measurement tools included those for screening, executive functioning, and ADHD symptoms.
In the practice project setting, no measurement tools were being utilized for adults with ADHD.
The articles included in the literature review were reviewed again for commonly used symptom
measurement tools since symptoms are the mainstay of the ADHD diagnosis. Commonly utilized
ADHD symptoms scales were the Adult ADHD Self-Report Scale (ASRS-v1.1) Symptom
Checklist, Conner’s Adult ADHD rating scale, Brown ADHD Scale (BADDS), Barkley Adult
ADHD Rating Scale (BAARS-IV), and the Wender Utah Rating Scale. Additionally, commonly
referenced guidelines in the literature review such as, NICE (2018), Canadian ADHD Practice
Guidelines (2018), and the American Academy of Pediatrics (2011) recommend the use of an
ADHD symptom scale based on DSM criteria. The use of measurement-based care with
commonly used self-report of symptoms could be assessed and implemented as needed. These
interventions could improve care of adults with ADHD in the primary care setting.
The Adult ADHD Self-Report (ASRS-v1.1) Symptom Checklist was identified as a
widely-used symptom scale which is freely available for healthcare providers (National
Comorbidity Survey, n.d.; Kessler et al., 2005). This scale was developed and validated for
assessing ADHD symptoms in adults based on DSM-IV diagnostic criteria for ADHD (Kessler
et al., 2005). The screening scale consists of 18-items and takes approximately five minutes to
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complete (Kessler et al., 2005). The ASRS-v1.1 was attractive for use in the primary care setting
because it is free to use, time-efficient, and easily correlates to DSM diagnostic criteria. The
symptoms of adult ADHD have not changed with the updates from DSM-IV to DSM-V criteria,
however the number of symptoms required for the diagnosis has decreased from six inattentive
or hyperactive symptoms to five in the DSM-V (Ustun et al., 2017). Therefore, the ASRS-v1.1
remains a valid tool for symptom assessment in adults with ADHD.
Other measurement tools were considered, but were either cost prohibitive or too long for
use in the primary care setting. The Conner’s Adult ADHD rating scale has a cost of $398 for the
complete evaluation kit (Conners, Erhardt, & Sparrow, n. d.). The Brown ADHD Scale
(BADDS) Complete Kit for adolescents and adults has a cost of $288 (Brown, 2018). The
Barkley Adult ADHD Rating Scale (BAARS-IV) is available for $165 (Barkley, 2018). Lastly,
the Wender Utah Rating Scale is a 61-item scale used to assess adults for ADHD by
retrospective recall of childhood ADHD symptoms (Ward, Wender, & Reimherr, 1993). The
Conner’s Adult ADHD rating scale, BADDS, and the BAARS-IV were considered too expensive
for this project. The Wender Utah Rating scale was too long to be used in a primary care
practice.
Chronic Care Model
The American Academy of Pediatrics (2011) recognizes ADHD as a chronic condition
which persists into adulthood. ADHD was originally defined in the pediatric population, but is
now recognized to have symptoms and functional impairments continue to affect individuals into
adulthood (Culpepper & Fried, 2013). Because ADHD is considered to be a chronic condition,
treatment should follow management principles of other chronic conditions such as asthma or
diabetes. The chronic care model can serve as a framework which results in improved health care
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services and outcomes. The chronic care model has several components which can be applied to
an ADHD treatment model. Community resources, self-management support, delivery of
medical services, decision support, and clinical information systems are components of the
chronic care model which can be applied to the treatment of adults with ADHD (Culpepper &
Fried, 2013).
ADHD is a disorder where the symptoms and functional goals may change across the
lifespan, so a standard “medicate and reassess” approach is inadequate for ADHD as well as
most chronic conditions (Culpepper & Fried, 2013). Appropriate management requires goal
directed treatment, patient education, and incorporation of complementary resources. A
component of the chronic care model is community resources which could be applied to adults
with ADHD by coordinating with support groups (Culpepper & Fried, 2013). Self-management
support in ADHD may include developing a patient centered treatment plan and goals
(Culpepper & Fried, 2013).
Another chronic care model component is delivery of medical services which, when
applied to ADHD care, could include integrating multidisciplinary care coordination (Culpepper
& Fried, 2013). Decision support could be applied to ADHD care by updating treatment
periodically to align with current guidelines. Lastly, the clinical information systems component
of the chronic care model could applied by optimizing access to patient and provider reports and
updating counseling information periodically (Culpepper & Fried, 2013).
Project Plan
Purpose of Project and Objectives
The chronic care model asserts that the care of chronic diseases such as ADHD is optimized
by the use of basic components from the model, including community resources, self-
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management support, delivery of medical services, decision support, and clinical information
systems (Culpepper & Fried, 2013). Components of this model were considered and incorporated
into the ADHD toolkit designed for provider use in the primary care setting. The goal of this
quality improvement project was to increase the frequency that providers use a validated ADHD
symptom scale in the treatment and diagnosis of ADHD in primary care. The clinical practice
question to be addressed was: Does implementation of an ADHD tool kit and a validated ADHD
symptom scale affect clinical practice surrounding the assessment and treatment of ADHD? The
objectives for this project were:
1.   To increase the use of ADHD assessment and symptom scales by providers within a
primary care clinic.
2.   To assess provider knowledge and clinical practices with the diagnosis, treatment, and
management of ADHD.
3.   To assess provider practices of medication prescription for the treatment of ADHD.
4.   To assess whether use of ADHD symptom scale and toolkit increases adherence to
evidence based practices of managing ADHD.
Design for the Evidence-based Initiative
For this quality improvement project, baseline data included primarily retrospective
record review and a survey of the providers. After determination and approval by the
organization and GVSU Institutional Review Boards [IRBs], the DNP student evaluated medical
records of adult patients (18+ years) with ADHD diagnoses that were seen in the clinic in the
prior five weeks for data collection as described in the methodology section below. Preimplementation data collection occurred in November, 2018. Additionally, pre-implementation
provider/staff surveys were distributed and collected after IRB approval. The intervention
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included the implementation of the Adult ADHD Self-Report Scale (ASRS v1.1) Symptom
Checklist and the ADHD toolkit. Beginning approximately two weeks following implementation
of the intervention (to allow for the usual chart preparation period), charts of all adult ADHD
patients seen in the clinic were retrospectively reviewed for a five-week post-intervention data
collection period. The post-intervention data collection occurred between January, 2019Feburary, 2019 .
Setting
The setting for this organizational assessment was a family practice primary care office in
the Midwest. This office is a part of a larger network of healthcare facilities throughout the
community and the nation. The health system is a nonprofit health care system which includes
five hospital campuses and more than 60 physician offices. The clinic is a part of a national
health system and seeks to provide compassionate and excellent care. The office is comprised of
15 providers who operate in work “pods” comprised of physicians, nurse practitioners or
physician assistants, and medical assistants. This structure allows more continuity of care and
flexibility for both acute and routine appointments. The office provides primary care to a large
array of patients ranging from pediatrics through older adults. The patient population in this
urban setting is very diverse in terms of ethnic and socioeconomic demographics. The lead
practice physician was the project site mentor for this quality improvement project.
Participants
A chart review of adult patients (aged 18 and older, excluding vulnerable populations)
with an ADHD diagnosis code (F90.0, 90.1, 90.2, 90.8, and 90.9) who were seen in this primary
care office during the project period were included. Additionally, providers of adult patients with
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ADHD in this primary care office were the primary participants of the quality improvement
project. A provider questionnaire was administered pre- and post-intervention to assess
knowledge and clinical practices surrounding ADHD care. Providers that are exclusively
pediatric providers were excluded.
Model Guiding Implementation: Model for Improvement
The Model for Improvement with Plan-Do-Study-Act cycles served as the theoretical
framework for implementation of the ASRS-v1.1 and the ADHD toolkit in the primary care
setting. The Model for Improvement with Plan-Do-Study-Act cycles has three fundamental
questions which form the premise of the model: “What are we trying to accomplish? How will
we know that a change is an improvement? and What change can we make that will result in
improvement?” (IHI, 2018, p.1). This model was developed by Associates in Process
Improvement and is recommended for quality improvement by the Institute for Healthcare
Improvement (IHI, 2018). The steps in this model are: forming the team, setting aims,
establishing measures, selecting changes, testing changes with Plan-Do-Study-Act cycle,
implementing changes, and spreading changes (IHI, 2018; Langley et al., 2009). The Model for
Improvement (Appendix D) is reproduced with permission from published John Wiley and Sons
(Appendix E).
Forming a Team. The quality improvement team was comprised of representatives
within the organization which represent different kinds of expertise (IHI, 2018). This project
team consisted of a family physician project leader, Doctor of Nursing Practice (DNP) student
leader, and site medical assistant (MA) staff. The core group of leaders of varied expertise
assisted in the implementation design and workflow for the ASRS-v1.1 and ADHD toolkit.
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Setting Aims. Setting aims is required to make improvements within an organization
(IHI, 2018). Aims should be both measurable and time-specific (IHI, 2018). The goal of this
quality improvement project was to implement the use of a validated symptom scale and
determine how the use of the scale affected clinical practices surrounding the care of adults with
ADHD. The timeframe for this project was as follows: propose to the doctoral project committee
at Grand Valley State University (GVSU) and the site mentor on November 5th, 2018, obtain
approval through the IRBs, collect pre-implementation data via provider survey and chart review
of adult patients with an ADHD diagnosis seen at the office in the prior five weeks, implement
the use of ASRS-v1.1 and ADHD toolkit, and evaluate measures beginning two weeks after
implementation.
Establishing Measures. Measurement allows the team to evaluate the process and make
changes as necessary (IHI, 2018). Measurements should bring knowledge into practice and
collect enough data to learn and complete another Plan-Do-Study-Act cycle (IHI, 2018).
Measurements for this quality improvement project align with project goals and objectives
discussed in the project plan portion of this document.
Selecting Changes. The primary change in this quality improvement process was
implementing the use of the Adults ADHD (ASRS-v1.1) Symptom Checklist into routine
evaluation of adults with ADHD in the primary care setting. If changes result in improvement,
the change can be expanded (IHI, 2018).
Testing Changes. The Model for Improvement suggests testing changes by trying a
change in a real work setting by using the Plan-Do-Study-Act cycle (IHI, 2018). By testing
changes, the organization can increase support by establishing that the change results in
improvement and decide whether the change results in improvement in the actual working
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environment (IHI, 2018). The steps for testing are planning the test with a plan for data
collection, trying the test on a small scale and begin data analysis, complete data analysis and
summarize results, and lastly to refine the change as needed from what was learned during the
testing period (IHI, 2018).
Implementing Changes. After successful testing on a small scale, the change may be
ready for implementation on a larger scale (IHI, 2018). The implementation step is solidifying a
change into organizational practices by affecting documentation, policies, training, and possibly
compensation (IHI, 2018). Implementation stage also utilizes Plan-Do-Study-Act cycles for
modifying the change as needed for the practice setting (IHI, 2018).
Spreading Changes. Spreading changes is the final step of implementing a change in the
Model for Improvement (IHI, 2018). This step involves replicating the change process in other
parts of the organization. For this quality improvement project, this would be the possibility of
implementing the Adult ADHD ASRS-v1.1 Symptom Checklist into other primary care settings
within the health system in the future.
Plan for Implementation
The Model for Improvement with Plan-Do-Study-Act cycles was best implemented
initially on a smaller scale with three providers initially to help the intervention gain momentum
within the project location. At the project site, there were 12 providers that manage and treat
patients with adult ADHD. Implementation began with three of these providers and their teams
to test the changes and adjust for any issues in workflow for the first week. Once implementation
was successful on this scale, the implementation was expanded to all the adult providers within
the office. This implementation plan allowed for an opportunity to refine the process as needed
to optimize uptake and buy-in within the office setting. The Adult ADHD ASRS-v1.1 Symptom
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Checklist and ADHD toolkit implementation affected the workflow of both providers and the
medical assistants. For successful implementation, medical assistants needed to ask adult patients
to complete the ASRS with their visit. Typically, for visits such as ADHD follow-up
appointments and routine physicals, chart preparation was completed two weeks in advance with
paperwork mailed to the patient. When completing chart preparation, the medical assistant could
include the ASRS in the mailing for adults with ADHD. If the patient presents with ADHD and
had not filled out the ASRS for the visit, the medical assistant instructed the patient to do so. The
medical assistant uploaded the form to the electronical medical record and gave the hard copy to
the provider for interpretation.
For adults with ADHD, providers should ensure the patients have completed the ASRS,
and then evaluate their current symptoms at their appointment. Providers should decide if an
intervention is necessary and treat the patient accordingly. If needed, the provider can set another
appointment with the patient to further evaluate ADHD symptoms. Providers should verify that
the ASRS was uploaded to the patient’s medical record.
Implementation Steps and Strategies
The ADHD toolkit included the Adult ADHD Self-Report Scale (ASRS-v1.1)
Symptom Checklist for patient use (Appendix F). The Adult ADHD Self-Report Scale
(ASRS-v1.1) is a three-page document with instructions on the first page and the value of
using a scale for ADHD on the third page. The ASRS-v1.1 is copyrighted by the World
Health Organization, but is freely available for use by healthcare providers, so long as the
appropriate citation is included. This has been highlighted in Appendix G. Next, the ASRS
Interpretation Guide (Appendix H) was created by the DNP student for quick interpretation of
ASRS Symptom Checklist results. Inattentive and hyperactive symptoms were highlighted for
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easy interpretation. This was refined for readability after the first Plan-Do-Study-Act cycle
(Appendix I). DSM-V symptom diagnostic criteria are highlighted with an ICD-10 coding
guide. Symptom definitions for ADHD, partial remission, and functional remission are
included. A provider survey cover letter (Appendix J) explained the purpose of the project to
providers and included an invitation to participate in the provider survey which was
distributed during the initial week of project implementation. A pre-implementation provider
survey (Appendix K) and a post-implementation provider survey (Appendix L) were utilized
to understand provider assessment and treatment of adult patients with ADHD in the primary
care setting.
The provider situation, background, assessment, recommendation (SBAR) document
(Appendix M) served as an educational tool to outline the reason for the project and the
selection of the ASRS measurement tool. The ASRS Medical Assistant Letter/Education
(Appendix N) explained the project and proposed workflow to incorporate the ASRS into
practice. The ASRS Medical Assistant Letter/Education was changed slightly after the first
Plan-Do-Study-Act cycle to clarify the workflow directions for the staff (Appendix O).The
ADHD Quality Improvement Education poster (Appendix P) provided a project explanation
and purpose in SBAR format and include a summary of workflow changes for both providers
and flow staff. This was utilized as the cover to the adult ADHD folders that were distributed
to providers and staff within the office. A Provider Medication Guide outlined available
medications for adult ADHD (Appendix Q). Lastly, the Provider Non-Pharmacological
Interventions Guide provided resources and education discussion points for providers to
discuss adult ADHD (Appendix R).
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Measures
Measurement of this quality improvement project began by evaluating demographic
information in the pre-implementation and post-implementation cohorts. Demographic
information included gender, age, and race to ensure that the population with ADHD in the preimplementation and post-implementation periods were similar. Secondly, measurements were
designed to align with project objectives.
The first objective, to determine whether use of ADHD scales by providers can be improved
in the primary care setting, was measured by documentation of a symptom scale during the visit
and type of visit. Use of ADHD measurement scales may vary depending on the reason for the
patient’s office visit. Additionally, the provider survey evaluated the use of a validated symptom
rating scale in question two, provider perception of usefulness of a symptom scale in question
three, and ease of documentation of ADHD symptoms in question seven. The second objective
was to assess provider knowledge and clinical practices with the diagnosis, treatment, and
management of ADHD.
The second objective was measured by timeframe of the patient’s last office for ADHD,
presence of a comprehensive ADHD evaluation on the chart of a patient given the ADHD
diagnosis, number of ADHD symptoms recorded in the history of present illness (HPI), and by
provider survey. The provider survey questions 1, 2, 8, and 9 addressed knowledge of adult
ADHD, use of an ADHD symptom scale, discussion of nonpharmacological treatment options,
and offering additional community resources to adults with ADHD.
The third objective, to assess provider practices of medication prescription for the treatment
of ADHD, was evaluated by whether the patient is receiving medications for ADHD at the last
visit, ADHD medication type, changes in medication dosage ever, change in medication dose
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during current visit, and by provider survey. Survey questions five and six address provider
confidence and understanding of medication management of adults with ADHD.
The fourth objective, to assess whether use of ADHD symptom scale and toolkit changes
providers practice in treatment of ADHD, was addressed by whether patient has an ADHD
follow up visit scheduled within the next six months, pre- and post-intervention medication
prescriptions, and by provider survey. Question four of the provider survey asked if the provider
knows who to ask with questions regarding ADHD management.
Data Collection Procedures
The project began immediately following IRB determination and permission from the
doctoral project committee containing representatives from Grand Valley State University and
the clinic. Pre-intervention data collection and provider survey occurred in the month of
November 2018. Implementation of the ADHD toolkit and ASRS in the clinic began with the
initial three providers and their teams during the week of November 12, 2018. During the
week of December 3, 2018, the implementation of the ADHD toolkit and the ASRS began
with the rest of the providers and their teams. Post-implementation data collection began in
January 2019 which allowed for a two-week chart preparation period. Data collection
continued for approximately five weeks from January 2019 through mid-February 2019.
Statistical analysis occurred at the end of February. The quality improvement project will be
available for dissemination and published through Grand Valley State University
ScholarWorks by April 2019.
This quality improvement project did not require a sample size estimation as all adult
patients with a diagnosis code for ADHD were evaluated during the project period. The
project period extended five weeks prior to implementation and five weeks after project
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implementation. A preliminary report was run during August 2018 which identified 238
unique adult patients with an ADHD diagnosis code that had been seen at the clinic in the
prior three months, averaging approximately 19 adults ADHD patients each week. A fiveweek sample was expected to yield approximately 95 adult patients for both the pre- and postimplementation period. The provider survey was distributed to all providers (MD, DO, NP,
PA) who evaluate and treat adult patients with ADHD. An Excel file was developed for
retrospective data collection, including the following items:
§   Pre- or post-intervention (pre-, post-)
§   Gender (male, female)
§   Age (in years)
§   Race (Caucasian, African American, Other)
§   Diagnosis code (F90.0 (predominantly inattentive); F90.1 (predominantly
hyperactive); F90.2 (combined type); F90.8 (other); F90.9 (unspecified); more
than one dx code)
§   Current visit type (initial evaluation ADHD, follow up ADHD, physical, sick
visit)
§   Last office visit for ADHD symptom evaluation (first visit, within last month,
within last 12 months, greater than 12 months)
§   Presence of comprehensive ADHD evaluation on chart (yes, no, referred, not
applicable)
§   Documentation of a symptom scale at visit (yes, no, no applicable)
§   Number of ADHD symptoms in HPI at last visit for ADHD (number of
symptoms)
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§   Scheduled a follow up ADHD visit within next six months (yes, no, no
applicable)
§   Receiving medications for ADHD at last visit (yes, no)
§   ADHD Medication type (long acting stimulant only, short acting stimulant only,
nonstimulant only, long acting + short acting stimulant combination, long acting
stimulant + nonstimulant combination, no medication)
§   Change in ADHD medication ever (yes, no, not applicable)
§   Change in ADHD medication last six months (yes, no, not applicable)
§   Change in ADHD medication current visit (yes, no, not applicable)
§   Change in ADHD medication dose at current visit (increase, decrease, no
change, not applicable)
§   ADHD Patient Education Documented (yes, no, not applicable)
An additional two items were added to the data collection after proposal defense and with the
IRB approval to account for what ASRS symptom scores and if an ADHD plan was in place.
These items were:
§   Greater than 5 inattentive or hyperactive symptoms on ASRS [red zone] (ASRS
not used, >5 symptoms, <5 symptoms)
§   Provider documented an ADHD Plan (yes, no)
The DNP student collected the de-identified data and entered the data into the Excel code
book attached on the project site. The de-identified data was stored on a password protected
device. The DNP student collaborated with a GVSU statistician graduate student assigned to
assist with this project for completion of statistical analysis. De-identified data was analyzed
using Statistical Analysis System (SAS) software.
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Data Management
Protected health information was accessed by the DNP student within the organizational
site using a systematic method. Patient records were identified for review by having a report
generated through the electronic medical record system by diagnosis code and date of visit by an
organizational site leader. Data collection only occurred on project site location. Personal
identifiers were not collected. Data was de-identified and coded into numeric data and
documented in the project Excel file. Data was only accessed by the principal investigator and
project team members including site mentor, GVSU faculty advisors, and GVSU statisticians
assisting with project. All files maintained for this quality improvement project were password
protected and could be provided to the clinic at any time, including at the conclusion of the
student-led project in April, 2019. Analysis and the final disposition of the data was reported in
statistical terms and descriptive statistics only. Publication or dissemination of results was in
descriptive terms only, the name and location of the organization was not identified. The DNP
student could provide information as requested. At the completion of the project in April 2019,
all study related documents will be transferred to the clinic. The DNP student has completed
human subjects training and Health Insurance Portability and Accountability Act (HIPAA)
training via Collaborative Institute Training Initiative and project design will reflect these
principles.
Analysis
Demographic data, including age, gender, and race were evaluated, analyzed, and
presented in the form of a table for the purpose of describing the pre-implementation patient
group and the post-implementation group. An assessment of normality was completed with
demographic data to establish that pre- and post- implementation groups are similar. Numeric
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variables were compared using t-tests or the appropriate nonparametric test if necessary
assumptions were not met. Data used in the t-tests were summarized and reported with means
and standard deviations. Data used in nonparametric tests were summarized using medians and
interquartile ranges. Categorical data was compared using chi-squared analyses with Fishers’
Exact tests. Frequencies and percent frequencies were reported for categorical data. All p-values
were reported and compared using a level of significance of alpha=0.05.
Resources & Budget
The budget for this quality improvement project was comprised of revenue and expenses.
Revenue sources represent value-added to the project and include time for the project manager as
well as team member time of the family physician project leader, registered nurse practice
manager, and practice flow staff. Additionally, time for family physicians to fill out the survey
was included. Consultations for statistician services and the ADHD expert were additional values
added to this project. These items were also included in the expenses, as cost which would need
to account for in the case of project replication. Additional expenses were the cost of printing
letters, surveys, and educational materials, as well as, the use of a computer to complete project
research and design, chart review, and dissemination reports.
The average hourly salary for a family physician leader is $93/ hour (Pay Scale, 2018a).
RN project leaders earn approximately $35/ hour (Pay Scale, 2018 b). Medical assistants were
key to model implementation planning and are paid approximately $14.50/ hour (Pay Scale,
2018 c). The psychiatric specialists, such as an ADHD expert, earns approximately $125/ hour
(Pay Scale, 2018d). The cost for input from an RN Practice manager was based on an hourly rate
of $30 (Pay Scale, 2018e). Consultation services of the statistician is based on an average hourly
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rate of $29 (Pay Scale, 2018f). The total expense of the project is projected to be $1040.00 as
outlined in the project budget (Appendix S).
Timeline
The timeline for this quality improvement project progressed in the following steps (Appendix
T):
1.   Met with clinic personnel to discuss project on July 11, 2018.
2.   Proposed project to doctoral project committee at Grand Valley State University to
the organizational representative, on November 5, 2018.
3.   Obtained approval through the clinic and Grand Valley State University IRB.
4.   Distributed Provider Surveys during November, 2018.
5.   Obtained report of adult (18+ years) ADHD patients seen at the clinic in previous
five weeks (November 2018) via report builder in the clinic electronic health record
provided by office manager.
6.   Reviewed medical records for applicable pre-implementation data and record deidentified data in project excel file (see attachment).
7.   Implemented the Adult ADHD Self-Report Scale (ASRS v1.1) Symptom Checklist
and ADHD provider toolkit with initial three providers and their teams in the office
location. In addition, the following steps will be completed:
a.   Utilized a Plan-Do-Study-Act model of quality improvement model by
Institute for Healthcare Improvement [IHI] (2017) to guide project
implementation
b.   Implemented project with office staff members (Flow Staff)
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i.   During chart preparation- identify adult patients with ADHD by
reviewing the problem list
ii.   Include ASRS with chart preparation packet
iii.   Complete ASRS during intake of adult with ADHD, if not already
complete
iv.   Give form to provider for scoring and interpretation
v.   Upload to patient’s current visit via scanning & uploading a
document to a chart protocol
c.   Implemented project with providers (physicians, physician assistants, and
nurse practitioners)
i.   If a patient has ADHD, ensure patient has completed ASRS
ii.   Evaluate current symptoms and utilize symptom review to guide
conversation and assess patient functional status
iii.   Intervention: Decide if a need for change in treatment plan is needed
and treat accordingly or set up future appointment for further
evaluation if needed. Educate/engage patient on diagnosis/treatment
plan
iv.   Ensure ASRS is uploaded to the chart for the visit
8.   Evaluated implementation process and workflow and made any changes necessary
during weeks of November 12, 19, and 26, 2018.
9.   Implemented the Adult ADHD Self-Report Scale (ASRS v1.1) Symptom Checklist
and ADHD provider toolkit with remaining nine providers and their teams during the
week of December 3, 2018.
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10.  Evaluated charts of adult (18+ years, excluding vulnerable populations) ADHD
patients seen at the office for five weeks post-implementation from January 2February 8, 2019.
11.  Submitted project data to GVSU statisticians by February 12, 2019.
12.  Completed statistical analysis during March, 2019.
13.  Project defense to GVSU faculty and organizational representative and publish
findings in GVSU ScholarWorks by April 30, 2019.
Sustainability Plan
  

This project demonstrates long-term sustainability because of the strategies utilized for

implementation. The use of the ASRS in practice will become easier as time continues and the
practice becomes solidified. The cost of sustaining operation of this project is low. Project
deliverables such as the ADHD toolkit and printed educational materials also contribute to the
sustainability of the project. Additionally, the project site mentor serves as the physician lead in
this practice and therefore will be well positioned to be the ADHD physician champion in this
office. The physician champion can contribute to sustainability by providing leadership on the
topic of ADHD and the process change. In accordance with the Model for Improvement, PlanDo-Study-Act cycles may be continued for implementation of the ADHD toolkit and the ASRS
with more providers. The final step in the Model for Improvement is spreading changes. The
project site mentor and physician champion serves on the organizational opioid task force which
has been charged with refining practices around opioid prescriptions within the organization.
Future goals of this task force may include refining practices around other controlled substances
such as benzodiazepines and stimulants. This project may serve as a basis for changes
surrounding stimulant prescription and the treatment of ADHD with a trialed ADHD toolkit and
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validated symptom measurement tool to be implemented at other primary care sites within the
organization.
Results
Implementation of ADHD toolkit with Plan-Do-Study- Act Model
The Model for Improvement with Plan-Do-Study-Act cycles served as the theoretical
framework for the implementation of the ASRSv1.1 and the ADHD toolkit in this primary care
setting. During the first PDSA cycle, the ADHD toolkit was implemented with three providers in
the office for two weeks. Several changes occurred as a result of the first PDSA cycle including
modification to the ASRS Interpretation Guide to increase readability (Appendix I) and
modification of workflow instructions for support staff (Appendix O). The workflow changes
were suggested by the support staff team as a simple and familiar method of uploading the ASRS
to the electronic medical record and would be easy to retrieve for reference in the future.
Additionally, during the first PDSA cycle, the ASRS interpretation guide was used to create an
transparent template for easy identification of clinically significant hyperactive and inattentive
symptoms. This was placed in a bright yellow folder with the ADHD Quality Improvement
Education Poster stapled to the front of the folder. Also included inside the folder were blank
ASRS forms for use, ASRS Staff Education, and provider education on pharmacological and
nonpharmacological interventions for adult ADHD.
After these changes were made during the initial PDSA cycle and were solidified with the
initial three providers and their teams, the ASRS implementation was expanded to the rest of the
providers in the office. ASRS folders were made for every provider and support staff team in the
office, which allowed easy access to the necessary resources for all team members. Additionally,
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the DNP student did proactively review patient charts to provide a list of patients who would be
coming into the office with ADHD.
Provider Survey
The pre-implementation provider survey was distributed to all 12 of the providers and
nine of these surveys were returned. The post-implementation provider survey was distributed to
10 of the 12 providers because two providers were out of the office for an extended period of
time. Five of the 10 post-implementation provider surveys were returned. The results of the
provider survey are summarized in Table 1.
The first question asked the providers to rate their knowledge of adult ADHD. In the preimplementation survey, 3/9 (33%) providers rated themselves as very low or low, 4/9 (44%)
rated themselves moderately, and 2/9 (22%) rated themselves as high or very high. In the postimplementation survey, 1/5 (20%) providers rated themselves as very low or low, 3/5 (60%)
rated themselves moderately, and 1/5 (20%) rated themselves as high or very high. The second
question inquired about provider use of a validated symptom scale. In the pre-implementation
survey, 6/9 (67%) providers reported never or rarely using a scale, 2/9 (22%) providers reported
sometimes using a scale, and 1/9 (11%) providers reported usually or always using a scale. In the
post implementation survey, 1/5 (20%) providers reported never or rarely using a scale, 3/5
(60%) reported using a scale “sometimes,” and 1/5 (20%) reported usually or always using a
scale. The third question asked about providers perspective on whether or not a symptom scale
would be helpful in the management of adult ADHD. On the pre-implementation survey, 1/9
(11%) providers reported a symptom scale was never or rarely helpful, 4/9 (44%) provider
reported a scale would be sometimes helpful, and 4/9 (44%) providers answered that a symptom
scale would be usually or always helpful. On the post-implementation survey, 1/5 (20%)
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providers reported a symptom scale was never or rarely helpful and 4/5 (80%) providers reported
a symptom scale was sometimes helpful.
Question four of the provider survey asked if the provider knew who to ask with
questions regarding ADHD management. In the pre-implementation survey, 1/9 (11%) providers
reported never or rarely knowing who to ask, 1/9 (11%) providers reported sometimes knowing
who to ask, and 7/9 (78%) providers reported usually or always knowing who to ask. In the postimplementation survey, 1/5 (20%) reported never or rarely, 1/5 (20%) reported sometimes, and
3/5 (60%) reported usually or always knowing who to ask. The fifth survey question asked about
confidence in medication management of adult ADHD. In the pre-implementation survey,
responses of very low or low were given by 2/9 (22%) providers, 4/9 (44%) providers responded
with moderate, and 3/9 (33%) providers have high or very high confidence with medication
management. In the post-implementation survey, 1/5 (20%) reported very low or low confidence,
2/5 (40%) reported moderate confidence, and 2/5 (40%) reported high or very high confidence in
medication management. Question six asked about understanding of medications and dosing for
adult ADHD. In the pre-implementation survey, 2/9 (22%) providers low or very low
understanding, 5/9 (56%) providers reported moderate understanding, and 2/9 (22%) providers
reported high or very high understanding. In the post implementation survey, 1/5 (20%)
providers reported low or very low understanding, 2/5 (40%) providers reported moderate
understanding, and 2/5 (40%) providers reported high or very high understanding.
Question seven asked providers about ease of documentation. In the pre-implementation
survey 2/9 (22%) providers reported documentation was never or rarely easy, 4/9 (44%)
providers reported sometimes documentation was easy, and 3/9 (33%) providers reported was
usually or always easy. In the post-implementation survey, 1/5 (20%) providers reported
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moderate ease of documentation and 4/5 (80%) providers reported documentation was usually or
always easy. The eighth question asked providers to rate how often they discussed nonpharmacologic interventions. In the pre-implementation survey, 4/9 (44%) providers reported
sometimes discussing nonpharmacological interventions and 5/9 (56%) providers reported
usually or always discussing nonpharmacological interventions for adult ADHD. In the postimplementation survey, 1/5 (20%) providers reported sometimes discussing nonpharmacologic
interventions and 4/5 (80%) providers reported usually or always discussing nonpharmacologic
interventions with adult ADHD patients. Lastly, question nine asked providers about offering
community resources, support groups, or professional support to adult ADHD patients. In the
pre-implementation survey, 3/9 (33%) providers reported never or rarely offering this
information, 3/9 (33%) providers reported sometimes offering these resources, and 3/9 (33%)
providers reported usually or always offering these resources. In the post-implementation survey,
2/5 (40%) providers reported never or rarely offering, 1/5 (20%) providers reported sometimes
offering, and 2/5 (40%) reported usually or always offering community resources to adults with
ADHD.
The open-ended question at the end of the surveys elicited some interesting comments.
Provider feedback had some mixed responses, with one provider stating that the ASRS was
helpful in “monitoring treatment response.” Whereas another provider noted on the post survey,
“I worry that rating scales (like pain scales + opioids) will cause escalation of stimulant dosing
and I am not comfortable with our current high prescribing.” On the survey, providers also noted
need for psychosocial supports including “I don’t know of any support groups for ADHD, would
appreciate this kind of info” and “more professional/social support.” Additionally, providers
highlighted diagnosis and treatment concerns including, “Do we over use stimulants for adults in
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the US. Is the adult ADHD diagnosis accurate for my patients?” and “Risk for abuse of these
meds; risk for aggravation of HTN [hypertension].” Lastly, providers noted need for additional
services including “better access to formal testing” and “better follow-up, more regular mental
health referrals to help manage a etiology for learning and managing life.”
Chart Audit Pre and Post Implementation
The chart audit included 56 pre-implementation visits and 55 post-implementation visits.
Each visit was categorized as either an initial evaluation for ADHD, follow-up visit for ADHD,
routine physical, or a sick visit. In the pre-implementation group there were three visits which
were classified as “sick visits,” whereas in the post-implementation group there were 14 sick
visits. Because the sick visit appointments were considered likely to differ in documentation and
focus of the appointment, these visits were excluded from the analysis. This left 53 patients in
the pre-implementation group and 41 patients in the post-implementation group. Patient
demographic variables, including gender, race, and age, were assessed for normality in the preand post-implementation groups. For gender in the pre-implementation group, 38/53 (72%) were
female and 15/53 (28%) were male. In the post-implementation group, 23/41 (56%) were female
and 18/41 (44%) were male. Gender demographics are outlined in Table 2. For patient race in the
pre-implementation group, 44/53 (83%) were Caucasian, 8/53 (15%) were African American,
and 1/53 (2%) were classified as other. In the post-implementation group, 34/41 (83%) were
Caucasian, 4/41 (10%) were African American, and 3/41 (7%) were classified as other. Race
demographics are outlined in Table 3. Groups did not differ with respect to gender (c2
(1)=2.4696, p=0.1161) or race (c2 (2)=2.1180, p=0.3468) and therefore the normality assumption
is met for the composition of the groups. The age distribution appears to be similar across the
pre- and post-implementation groups (Figure 1).
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The primary goal of this project was to implement the use of the ASRS in the primary
care setting. Utilization of a measurement-based tool for adult ADHD was a new practice change
in this setting and there was no prior use of or documentation with a symptom scale prior to the
beginning of this project. In the pre-implementation group, there was zero use of ADHD
symptom scales, but in the post-implementation group, 51.22% providers had used the symptom
scale during their visit. The zero count in the pre-implementation group does not provide an
opportunity for a reliable statistic to be produced, however is a noteworthy uptake in the use of
the scale. Thus, the project was considered to be successful.
As a consequence of the use of the ASRS in the adult ADHD population in the primary
care setting, there were no other significant outcomes noted in the five-week postimplementation group. In the pre- and post-implementation groups, there were no significant
differences in the provider documenting a plan for ADHD, scheduling a follow-up visit for
ADHD within next six months, or making changes to medication type or dose. Additionally, no
significant changes were found for documentation of ADHD education, diagnosis code
frequency, or number of ADHD symptoms.
Despite insignificant outcome measures, there were two variables that were interesting on
the management of ADHD in this primary care setting. The variable that evaluated if more than
five inattentive or hyperactive symptoms were clinically significant on the ASRS yielded
interesting results. In the post-implementation group, 20/41 (48%) did not use the ASRS.
However, among those that did use the ASRS, 12/21 (57%) had more than five clinically
significant symptoms, indicating that the patient’s symptoms are still meeting diagnostic criteria
for adult ADHD. There were 9/21 (43%) of those who used the ASRS who had less than five
clinically significant inattentive or hyperactive symptoms, indicating that these patients may be
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in partial or full remission for adult ADHD. In this quality improvement project, 90% of patients
were on medications to treat their ADHD; however, only 43% reported well controlled
symptoms.
Another interesting variable was the variable for medication type which evaluated if a
patient was on a short-acting stimulant only, long-acting stimulant only, nonstimulant only,
combination of long and short acting stimulant, long-acting stimulant and nonstimulant
combination, or no medication. Although no significant changes were noted between groups, the
total frequencies and percentages of each medication type is interesting. Of the 94 total patients
in this project, 37 (39%) were on a long-acting stimulant, 35 (37%) were on short acting
stimulants, 4 (4%) were on a nonstimulant, 7 (7%) were on a long-acting plus a short-acting
stimulant combination, 1 (1%) was on a long-acting plus non-stimulant combination, and 10
(10%) were on no medication. A medication type pie chart is located in Figure 2.
Discussion
Measurement-based care for mental health concerns is intended to “enhance precision
and consistency in disease assessment, tracking, and treatment to achieve optimal outcomes”
(Fortney et al., 2017, p. 180). Symptom rating scales are intended to be used as a supplement to
clinical judgement and as a starting point in the provider’s evaluation of treatment efficacy
(Fortney et al., 2017). Outcomes are most improved when symptom assessment coincides with a
clinical encounter and is assessed frequently (Fortney et al., 2017). Patients often report that
measurement-based care complements the provider’s assessment and helps them better
understand their illness and express their symptoms to providers (Fortney et al., 2017). Assessing
symptom response by comparing current symptom severity with prior symptom severity is
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notably more difficult when using a paper-and-pencil measurement-based care tool versus an
electronic version (Fortney et al., 2017).
This DNP quality improvement project was able to demonstrate substantial improvement
in the use of the ASRS over the five-week post-implementation period. The project was unable
to demonstrate further significant outcomes or practice changes as a result of the use of the
symptom scale. Given the short evaluation period, the lack of positive long-term outcomes is
unsurprising. The adult ADHD project has highlighted a couple areas for improvement in the
care of adults with ADHD in the primary care setting. In this project, 57% of adult patients still
had clinically significant symptoms. Additionally, 37% of patients were on short-acting
stimulants only. Short-acting and intermediate-acting stimulants are considered second-line
treatment agents for adults with ADHD (CADDRA, 2018). Long-acting stimulants are
considered first-line therapy because they have the best risk-benefit profile, effectiveness, and
duration (CADDRA, 2018). Additionally, long-acting stimulants reduce the need for multiple
dosages and consequently increase compliance, symptom coverage, and treatment response
(CADDRA, 2018). Optimal treatment is defined as symptoms have decreased and there has been
improvement in general functioning (CADDRA, 2018). The results from this indicate that
perhaps there is a large proportion of adult ADHD patients that have suboptimal treatment
response and are not being treated with first-line medications. This may indicate a need for
further study and support of providers in treating adults with ADHD.
The chronic care model served as an important basis for this project because ADHD is
now known to be a lifelong condition that affects the individual across the life span (Culpepper
& Fried, 2013). Appropriate management requires assessment and reassessment, a goal-directed
treatment plan, utilization of ancillary resources, and patient education (Culpepper & Fried,
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2013). By beginning to utilize an evidence-based measurement tool for symptom assessment,
this primary care providers in this office have taken a challenging step in the appropriate
management for adults with ADHD.
Limitations
This quality improvement project for improving use of the ASRS in adults with ADHD in
the primary care setting had several limitations. Provider responses to the post-intervention
survey were limited. Two providers in the office were out for extended leave and several others
did not return the voluntary surveys. Another project limitation would be the length of
implementation and evaluation time. The project was evaluated over a post-implementation
period of five weeks. Maximum benefit from the use of measurement-based care will not be seen
after only one symptom assessment, but over a time with repeated assessments.
Another significant barrier to this project was that the ASRS was not built into the
electronic medical record (EMR). The organization is planning to change electronic medical
record providers and therefore during this project implementation, changes to the current EMR
were not considered. Different patients were compared pre- and post- implementation which may
affect the outcomes.
Another limitation was the method of data collection did not necessarily represent the
patients well, for example, some patients were managed by another provider outside of the office
such as a psychiatrist or ADHD specialist, however they were still coded for ADHD at their visit.
Another limitation was that the visit types for this project were limited to initial evaluation of
ADHD, follow-up ADHD, routine physical, and sick visit. Some patients, however, may not
have fit neatly into these categories; other reasons for visits included emergency room follow-up,
follow-up on chronic conditions, or follow-up on another mental health condition such as
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depression. Another significant barrier was the generally low volume of adult patients with
ADHD. In a given week, there may be approximately 10-15 adult patients with ADHD that were
scheduled in the office, however, at most a single provider would only see four of these patients.
Additionally, throughout the course of this project, adults with ADHD have a high risk of
cancelling or no-showing their appointments. This is not surprising given that core symptoms of
ADHD include inattention, hyperactivity, and impulsivity which often manifest in organizational
problems such as difficulty with time management and missed appointments (CADDRA, 2018).
Stakeholder Support and Sustainability
This project has several invested stakeholders, including the project site mentor and other
physicians who frequently treat patients with adult ADHD. During project implementation, the
strongest physician stakeholders were those who treated the highest number of adults with
ADHD. Providers who treated few patients with ADHD were less invested in adopting the use of
the ASRS. Additionally, the support staff were instrumental in making practice change. The
support staff were invested in helping design the practice change and implementing it in adults
with ADHD. Patients were also a stakeholder because they were asked to complete the ASRS at
their visit. Lastly, organizational leaders such as the office managers were an invaluable support
to the project. The office managers were essential in obtaining the reports necessary to complete
data collection for the project.
The use of the ASRS and the ADHD toolkit demonstrates sustainability due to the
strategic implementation plan. Unfortunately, the ASRS could not be integrated with the EHR
due to the organizational plan to change EHR providers. However, the implementation workflow
is easy and has become a more solidified practice through the duration of the project. The cost of
sustaining the project is low as the toolkit folders and educational information have already been
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distributed and there is minimal cost with uploading the document to the chart. The only ongoing
cost to sustaining the use of the adult ADHD toolkit would be printing copies of the ASRS,
which is minimal. The site mentor also serves as the physician practice leader and has agreed to
continue to serve as the physician champion for adult ADHD in the practice.
Implications for Practice
ADHD affects the lives of many adults due to the wide variety of functional impairments
that affect many areas of their lives. Measurement-based care is considered the standard of care
for ADHD along with most other psychiatric conditions. Measurement-based care is most
effective when used systematically over time as a way to adjust treatment (Wray, Ritchie, Oslin,
& Beehler, 2018). Benefits of measurement-based care include improvement of treatment
fidelity, provider-patient communication, and patient engagement (Wray et al., 2018). However,
few health care providers have adopted the use of standardized instruments for mental health
concerns (Wray et al., 2018). Measurement-based care was implemented in this practice setting
through the use of the ASRS and ADHD toolkit for adults with ADHD. Some providers will
need continued education, others accepted this new tool willingly and change was easily
established. The primary purpose of this intervention was to increase provider use of a
standardized assessment tool for adults with ADHD. Through the use of the ASRS and the adult
ADHD toolkit, providers were able to adopt the of a standardized tool to begin a more
comprehensive assessment of adult ADHD.
The use of the Model for Improvement with Plan-Do-Study-Act cycles served as an
important component to the implementation of the ASRS and ADHD toolkit in the primary care
setting. The steps of forming a team to promote stakeholder investment and making smaller scale
changes before office-wide implementation was helpful in the success of the project.
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Additionally, this project implemented components of the chronic care model for improved
outcomes in the treatment and management of adults with ADHD.
Reflection of Doctor of Nursing Practice Essentials
DNP students are required to meet eight essential competencies to graduate in good
standing as required by the American Association of Colleges of Nursing [AACN] (AACN,
2006). These essential competencies are crucial for success in the nurse practitioner role. The
eight Essentials were developed through the course of the DNP education and this project
implementation.
Scientific Underpinnings for Practice
The first Essential contributes to practice by integrating nursing science with knowledge
from other areas including ethics, biophysical, psychosocial, analytical, and organizational
sciences to achieve high level nursing practice (AACN, 2006). Additionally, the use of scientific
theories and concepts to guide and evaluate practice is necessary (AACN, 2006). In this project,
there were several examples of use of this competency, including the use of a comprehensive
literature review on the topic of ADHD and evidence-based practices. Practices found in the
literature review were incorporated into the project implementation. Additionally, by using the
chronic care model and the model for improvement for project implementation the DNP student
demonstrated this competency.
Organizational and Systems Leadership
Essential II provides a competency for organizational and systems leadership for quality
improvement (AACN, 2006). This Essential ensures the development and evaluation of care
delivery approaches to meet the needs of patient populations and ensures accountability for the
quality of care and patient safety within the health organization (AACN, 2006). This DNP
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project demonstrated competency in Essential II by nature of being a quality improvement
project. Through the use of an organizational assessment, the needs of adult ADHD patients
within the primary care setting were assessed and the quality improvement project was designed
to improve the care of these patients. The Plan-Do-Study-Act model was used to effectively
implement the new process in this primary care setting.
Clinical Scholarship and Analytical Methods
The third Essential focuses on using analytic methods to evaluate existing evidence to
implement into practice and direct quality improvement methods to promote safe, effective,
efficient, and patient-centered care (AACN, 2006). Information technology and research
methods should be used to collect and analyze data and findings should be disseminated to
improve healthcare outcomes (AACN, 2006). The adult ADHD quality improvement project
demonstrated this Essential by designing the intervention and implementation to align with
current evidence. Additionally, data was collected and analyzed using appropriate statistical
methods and disseminated through presentation and publication. Through integration of the
chronic care model into this DNP project, clinical scholarship was demonstrated in applying best
practices to a patient care setting.
Information Systems Technology
Use of information technology is essential to DNP competency and practice in the
healthcare field. This competency highlights the use of technology to evaluate and monitor
quality improvement and demonstrate the conceptional ability and technical skills to evaluate
practice data (AACN, 2006). This project demonstrated competency in information technology
by use of the organization EHR for data collection via reports and chart review. Additionally, an
electronic spreadsheet was used to code and store data for analysis. Analysis was completed
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using statistical software. Ethical guidelines were followed in accordance with the institutional
review board to maintain confidentiality with patient data.
Advocacy for Health Care Policy
Essential V, advocacy for health care policy, prepares the DNP student to analyze health
policy, demonstrate leadership in development and implementation of health policies at all
levels, influence and educate policy makers, and advocate for the nursing profession and ethical
policies (AACN, 2006). Although this project did not require a direct policy change within the
organization, organizational policy was followed through the process of IRB proposal and
project approval. Lastly, this DNP student was able to demonstrate competency in this area by
attending Advocacy Day at the state capitol to support state level policies and educate lawmakers
on the influence and practice rights of nurse practitioners.
Interprofessional Collaboration
The DNP student should master Essential VI, interprofessional collaboration, to improve
patient and population health outcomes (AACN, 2006). In this Essential, the DNP student should
employ effective communication and collaborative skills to implement standards of care and
practice guidelines (AACN, 2006). Additionally, the DNP student can lead the interprofessional
team to create a change in the health care system (AACN, 2006). This competency was
demonstrated through the implementation of the ASRS and adult ADHD toolkit in the primary
care setting. The DNP student created the project plan and guided its implementation through the
use of clinical practice guidelines.
Clinical Prevention and Population Health
Essential VII represents foundational DNP knowledge of clinical prevention and
population health for improving the nation’s health competencies (AACN, 2006). This Essential
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requires the DNP student to analyze scientific data at the individual, aggregate and population
level to develop and implement interventions to address gaps in care (AACN, 2006). During the
project planning, the DNP student analyzed data specific to the adult ADHD population in the
primary care setting to assess for practice gaps in care delivery.
Advanced Nursing Practice
The final DNP Essential is advanced nursing practice competencies which prepares
students to function in their roles. This competency requires the student to conduct a
comprehensive and systematic assessment of health and illness parameters, design and
implement therapeutic interventions, and educate others through complex health transitions
(AACN, 2006). The DNP student demonstrated this competency by acting as a change agent in
the implementation of the ASRS and adult ADHD toolkit in the primary care setting. The use of
a standardized assessment tool for adult ADHD was a new practice that had not been used
previously in this office, the DNP student guided this practice change through education during
this transition. Additionally, the practice change was implemented using the evidence-based
Model for Improvement and utilized Plan-Do-Study-Act cycles for quality improvement.
Dissemination of Outcomes
The results of this adult ADHD quality improvement project will be disseminated
through several outlets. The DNP student will publicly present the project at the university’s
final defense in April, 2019. The DNP student will present the findings of this project to an
organizational representative at the final defense. Lastly, the DNP student will publish these
outcomes to the university database, ScholarWorks.
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Conclusion
Adult ADHD is a significant mental health disorder that is routinely managed in the
primary care setting. Although measurement-based care is considered the standard of practice
and is recommended by numerous guidelines, it is rarely used in the primary care setting.
Through the implementation of the ASRS and the adult ADHD toolkit, practice changes have
begun in the care of adults with ADHD. Routinely using an evidence-based tool to assess for
symptoms can improve outcomes over time. ADHD is a chronic condition which should be
assessed and managed routinely with a standardized assessment tool such as the ASRS.
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Tables
Table 1
Pre- and Post- Intervention Provider Survey

Question 1: I would rate my knowledge of ADHD as
______.
Question 2: I routinely use a validated symptom rating
scale.
Question 3: I think a symptom scale is _____ helpful in
the management or treatment of ADHD.
Question 4: I know who to ask if I have a question
regarding ADHD management.
Question 5: My confidence in medication management
of an adult with ADHD is: _____.
Question 6: My understanding of medications and
dosing for an adult with ADHD is:
Question 7: Documentation of ADHD symptoms and
management plan is easy.
Question 8: I routinely discuss nonpharmacological
treatment options with my adult patients with ADHD.
Question 9: I offer information on community
resources, support groups, or professional support to
adults with ADHD

  

Pre- or
PostImplement
ation
PrePostPrePostPrePostPrePostPrePostPrePostPrePostPrePostPrePost-

Very low or
low/ Never
or rarely

Moderate/
Sometimes

High or very
high/ Usually
or always

3/9 (33%)
1/5 (20%)
6/9 (67%)
1/5 (20%)
1/9 (11%)
1/5 (20%)
1/9 (11%)
1/5 (20%)
2/9 (22%)
1/5 (20%)
2/9 (22%)
1/5 (20%)
2/9 (22%)
0/5 (0%)
0/9 (0%)
0/5 (0%)
3/9 (33%)
2/5 (40%)

4/9 (44%)
3/5 (60%)
2/9 (22%)
3/5 (60%)
4/9 (44%)
4/5 (80%)
1/9 (11%)
1/5 (20%)
4/9 (44%)
2/5 (40%)
5/9 (56%)
2/5 (40%)
4/9 (44%)
1/5 (20%)
4/9 (44%)
1/5 (20%)
3/9 (33%)
1/5 (20%)

2/9 (22%)
1/5 (20%)
1/9 (11%)
1/5 (20%)
4/9 (44%)
0/5 (0%)
7/8 (78%)
3/5 (60%)
3/9 (33%)
2/5 (40%)
2/9 (22%)
2/5 (40%)
3/9 (33%)
4/5 (80%)
5/9 (56%)
4/5 (80%)
3/9 (33%)
2/5 (40%)
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Table 2
Pre- and Post-Intervention by Gender
Pre- or postintervention
Pre-intervention
frequency and percent
Post-intervention
frequency and percent
Total frequency and
percent

  

Gender
Female
38
71.70%
23
56.10%
61
64.89%

Male
15
28.30%
18
43.90%
33
35.11%

Total
53
56.38%
41
43.62%
94
100.00
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Table 3
Pre- and Post-Intervention by Race
Pre- or postintervention

Race
Caucasian

Pre-intervention
frequency and
percent
Post-intervention
frequency and
percent
Total frequency
and percent

  

Other

Total

44
83.02%

African
American
8
15.09%

1
1.89%

53
56.38%

34
82.93%

4
9.76%

3
7.32%

41
43.62%

78
82.98%

12
12.77%

4
4.26%

94
100.00%
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Figures
Figure 1
Histogram of Age Distribution in Pre- and Post- Implementation Groups
Pre or post intervention = pre

Pre or post intervention = post
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Figure 2
Pie Chart of Total Medication Type

Medication  Type
Long-‐Acting  Only
Short-‐Acting  Only
Non-‐Stimulant  Only
Long-‐Acting  +  Short-‐Acting
Combination
Long-‐Acting  +  Non-‐stimulant
combination
No  Medication
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Appendices
Appendix A
Burke-Litwin Causal Model of Change

Burke, W. W., & Litwin, G. H. (1992). A causal model of organizational performance and
change. Journal of Management, 18(3), 523-545. Used with permission from Sage Publishing.
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Permission for Use of Materials
Permission to use Burke-Litwin Model from Sage Publishing
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Appendix B
SWOT Analysis of the Organization
Strengths
•   This office piloted the opioid
controlled substances initiative
recently
•   Michigan law changes for controlled
substances may motivate providers
and staff to adopt an evidence-based
practice surrounding stimulant
prescription
•   Opportunity for standardized care
•   Chart analysis to be completed
through chart review and intervention
does not directly involve patients
•   Team-based environment
•   Involved physician leadership
•   Validated adult ADHD Symptom
Checklist (ASRS v1.1) is freely
available for use.
•  
•  
•  
•  
•  
•  

  

Opportunities
CMS has a quality measure for ADHD
care in children, may increase
reimbursement for this measure
Improving quality of care for patients
with ADHD
May allow for closer monitoring of
ADHD patients and improved patient
satisfaction
Improve provider knowledge and
comfort with diagnosis and treatment
of ADHD
Improve access to treatment for
mental health
Improved documentation and
collaboration between care providers

Weaknesses
•   No CMS quality measure for ADHD
in adults
•   No current standard of practice
surrounding ADHD care
•   Documentation of ADHD symptoms
is not simple in current charting
system
•   May increase patient visits
•   May not have easy access to
adjunctive treatments for ADHD such
as therapy

Threats
•   Funding limitations for initiation of
new workflow for ADHD
•   Staff schedules predominately include
routine screenings and quality
measures, may be overwhelming to
change practice
•   Lack of buy-in of organizational
leaders, and office staff could severely
limit quality improvement
opportunities and sustainability of the
intervention.
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Appendix C
PRISMA Flow diagram of literature search selection process
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Appendix D
Model for Improvement

Langley, G. J., Moen, R. D., Nolan, K. M., Nolan, T. W., Norman, C. L., & Provost, L. P.
(2009). The improvement guide: A practical approach to enhancing organizational performance
(2nd ed). Used with permission from John Wiley and Sons.
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Appendix E
Permission to Use Model for Improvement

Book:

Author:

The Improvement Guide: A
Practical Approach to Enhancing
Organizational Performance, 2nd
Edition

Logged in as:
Danielle Miller

Gerald J. Langley, Ronald D. Moen,
Kevin M. Nolan, Thomas W. Nolan,
Clifford L. Norman, Lloyd P.
Provost

Publisher: John Wiley and Sons
Date:

Apr 1, 2009

Copyright © 2009, John Wiley and Sons

Order Completed
Thank you for your order.
This Agreement between Ms. Danielle Miller ("You") and John Wiley and Sons ("John Wiley and Sons")
consists of your license details and the terms and conditions provided by John Wiley and Sons and
Copyright Clearance Center.
Your confirmation email will contain your order number for future reference.
printable details
License Number

4442761115751

License date

Oct 05, 2018

Licensed Content
Publisher

John Wiley and Sons

Licensed Content
Publication

Wiley Books

Licensed Content Title

The Improvement Guide: A Practical Approach to Enhancing Organizational Performance, 2nd
Edition

Licensed Content Author Gerald J. Langley, Ronald D. Moen, Kevin M. Nolan, Thomas W. Nolan, Clifford L. Norman, Lloyd
P. Provost
Licensed Content Date

Apr 1, 2009

Licensed Content Pages 512
Type of use

Dissertation/Thesis

Requestor type

University/Academic

Format

Print and electronic

Portion

Figure/table

Number of
figures/tables

1

Original Wiley
figure/table number(s)

Model for Improvement

Will you be translating? No
Title of your thesis /
dissertation

ADHD Quality Improvement

Expected completion
date

Apr 2019

Expected size (number
of pages)

30

Requestor Location

Ms. Danielle Miller
4761 Shade Leaf Lane SE
GRAND RAPIDS, MI 49546
United States
Attn: Ms. Danielle Miller

Publisher Tax ID

EU826007151

Total

0.00 USD
ORDER
ORDER MORE
MORE

CLOSE
CLOSE WINDOW
WINDOW

Copyright © 2018 Copyright Clearance Center, Inc. All Rights Reserved. Privacy statement. Terms and Conditions.
Comments? We would like to hear from you. E-mail us at customercare@copyright.com
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Appendix F
Adult ADHD Self-Report Scale (ASRS-v1.1) Symptom Checklist for Patient Use

Adult A D H D Self-Report Scale (ASRS-v1.1) Symptom Checklist
Instructions
The questions on the back page are designed to stimulate dialogue between you and your patients and to help
confirm if they may be suffering from the symptoms of attention-deficit/hyperactivity disorder (ADHD).
Description: The Symptom Checklist is an instrument consisting of the eighteen DSM-IV-TR criteria.
Six of the eighteen questions were found to be the most predictive of symptoms consistent with
A D H D. These six questions are the basis for the ASRS v1.1 Screener and are also Part A of the
Symptom Checklist. Part B of the Symptom Checklist contains the remaining twelve questions.
Instructions:
Symptoms
1. Ask the patient to complete both Part A and Part B of the Symptom Checklist by marking an X
in the box that most closely represents the frequency of occurrence of each of the symptoms.
2. Score Part A. If four or more marks appear in the darkly shaded boxes within Part A then the
patient has symptoms highly consistent with A D H D in adults and further investigation is
warranted.
3. The frequency scores on Part B provide additional cues and can serve as further probes into the
patient’s symptoms. Pay particular attention to marks appearing in the dark shaded boxes. The
frequency-based response is more sensitive with certain questions. N o total score or diagnostic
likelihood is utilized for the twelve questions. It has been found that the six questions in Part A
are the most predictive of the disorder and are best for use as a screening instrument.
Impairments
1. Review the entire Symptom Checklist with your patients and evaluate the level of impairment
associated with the symptom.
2. C onsider work/school, social and family settings.
3. Symptom frequency is often associated with symptom severity, therefore the Symptom
Checklist may also aid in the assessment of impairments. If your patients have frequent
symptoms, you may want to ask them to describe how these problems have affected the ability
to work, take care of things at home, or get along with other people such as their
spouse/significant other.
History
1. Assess the presence of these symptoms or similar symptoms in childhood. Adults who have
A D H D need not have been formally diagnosed in childhood. In evaluating a patient’s history,
look for evidence of early-appearing and long-standing problems with attention or self-control.
Some significant symptoms should have been present in childhood, but full symptomology is not
necessary.
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Adult ADHD Self-Report Scale (ASRS-v1.1) Symptom Checklist

Very Often

Often

Sometimes

Rarely

Today’s Date

Please answer the questions below, rating yourself on each of the criteria shown using the
scale on the right side of the page. As you answer each question, place an X in the box that
best describes how you have felt and conducted yourself over the past 6 months. Please give
this completed checklist to your healthcare professional to discuss during today’s
appointment.

Never

Patient Name

1. How often do you have trouble wrapping up the final details of a project,
once the challenging parts have been done?
2. How often do you have difficulty getting things in order when you have to do
a task that requires organization?
3. How often do you have problems remembering appointments or obligations?
4. When you have a task that requires a lot of thought, how often do you avoid
or delay getting started?
5. How often do you fidget or squirm with your hands or feet when you have
to sit down for a long time?
6. How often do you feel overly active and compelled to do things, like you
were driven by a motor?

Part A
7. How often do you make careless mistakes when you have to work on a boring or
difficult project?
8. How often do you have difficulty keeping your attention when you are doing boring
or repetitive work?
9. How often do you have difficulty concentrating on what people say to you,
even when they are speaking to you directly?
10. How often do you misplace or have difficulty finding things at home or at work?
11. How often are you distracted by activity or noise around you?
12. How often do you leave your seat in meetings or other situations in which
you are expected to remain seated?
13. How often do you feel restless or fidgety?
14. How often do you have difficulty unwinding and relaxing when you have time
to yourself?
15. How often do you find yourself talking too much when you are in social situations?
16. When you’re in a conversation, how often do you find yourself finishing
the sentences of the people you are talking to, before they can finish
them themselves?
17. How often do you have difficulty waiting your turn in situations when
turn taking is required?
18. How often do you interrupt others when they are busy?

Part B
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The Value of Screening for Adults With ADHD

Research suggests that the symptoms of ADHD can persist into adulthood, having a significant
impact on the relationships, careers, and even the personal safety of your patients who may
suffer from it.1-4 Because this disorder is often misunderstood, many people who have it do not
receive appropriate treatment and, as a result, may never reach their full potential. Part of the
problem is that it can be difficult to diagnose, particularly in adults.
The Adult ADHD Self-Report Scale (ASRS-v1.1) Symptom Checklist was developed
in conjunction with the World Health Organization (WHO), and the Workgroup on Adult
ADHD that included the following team of psychiatrists and researchers:
•

Lenard Adler, MD
Associate Professor of Psychiatry and Neurology
New York University Medical School

•

Ronald C. Kessler, PhD
Professor, Department of Health Care Policy
Harvard Medical School

•

Thomas Spencer, MD
Associate Professor of Psychiatry
Harvard Medical School

As a healthcare professional, you can use the ASRS v1.1 as a tool to help screen for ADHD in
adult patients. Insights gained through this screening may suggest the need for a more in-depth
clinician interview. The questions in the ASRS v1.1 are consistent with DSM-IV criteria and
address the manifestations of ADHD symptoms in adults. Content of the questionnaire also
reflects the importance that DSM-IV places on symptoms, impairments, and history for a correct
diagnosis.4
The checklist takes about 5 minutes to complete and can provide information that is critical
to supplement the diagnostic process.

References:
1.
Schweitzer JB, et al. Med Clin North Am. 2001;85(3):10-11, 757-777.
2.
Barkley RA. Attention Deficit Hyperactivity Disorder: A Handbook for Diagnosis and Treatment. 2nd ed. 1998.
3.
Biederman J, et al. Am J Psychiatry.1993;150:1792-1798.
4.
American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision.
Washington, DC, American Psychiatric Association. 2000: 85-93.
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Adult ADHD Self-Report Scale (ASRS-v1.1) Symptom Checklist

Very Often

Often

Sometimes

Rarely

Today’s Date

Please answer the questions below, rating yourself on each of the criteria shown using the
scale on the right side of the page. As you answer each question, place an X in the box that
best describes how you have felt and conducted yourself over the past 6 months. Please give
this completed checklist to your healthcare professional to discuss during today’s
appointment.

Never

Patient Name

1. How often do you have trouble wrapping up the final details of a project,
once the challenging parts have been done?
2. How often do you have difficulty getting things in order when you have to do
a task that requires organization?
3. How often do you have problems remembering appointments or obligations?
4. When you have a task that requires a lot of thought, how often do you avoid
or delay getting started?
5. How often do you fidget or squirm with your hands or feet when you have
to sit down for a long time?
6. How often do you feel overly active and compelled to do things, like you
were driven by a motor?

Part A
7. How often do you make careless mistakes when you have to work on a boring or
difficult project?
8. How often do you have difficulty keeping your attention when you are doing boring
or repetitive work?
9. How often do you have difficulty concentrating on what people say to you,
even when they are speaking to you directly?
10. How often do you misplace or have difficulty finding things at home or at work?
11. How often are you distracted by activity or noise around you?
12. How often do you leave your seat in meetings or other situations in which
you are expected to remain seated?
13. How often do you feel restless or fidgety?
14. How often do you have difficulty unwinding and relaxing when you have time
to yourself?
15. How often do you find yourself talking too much when you are in social situations?
16. When you’re in a conversation, how often do you find yourself finishing
the sentences of the people you are talking to, before they can finish
them themselves?
17. How often do you have difficulty waiting your turn in situations when
turn taking is required?
18. How often do you interrupt others when they are busy?

Part B

!
!
ADHD%ASRS!Symptom!Checklist!v1.1!is!copyrighted!by!the!World!Health!Organization!and!is!
available!for!unrestricted!use.!!
!
Kessler,!R.!C.,!Adler,!L.,!Ames,!M.,!Demler,!O.,!Faraone,!S.,!Hiripi,!E.,!Howes,!M.!J.,!Jin,!R.,!Secnik,!
K.,!Spencer,!T.,!Ustun,!T.!B.,!&!Walters,!E.!E.!(2005).!The!World!Health!Organization!Adult!
ADHD!Self%Report!Scale!(ASRS).!Psychological+Medicine,+35(2),!245%256.!!
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Appendix G
Adult ADHD Self-Report Scale (ASRS-v1.1) Permission for Use
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Appendix H
ASRS Interpretation Guide
CODING
F90.0 Predominantly Inattentive
F90.1 Predominantly Hyperactive
F90.2 Combined Type =
criteria for BOTH inattentive and
hyperactive met

Adult ADHD Self-Report Scale (ASRS-v1.1) Symptom Checklist

Very Often

Often

Sometimes

Rarely

Today’s Date

Please answer the questions below, rating yourself on each of the criteria shown using the
scale on the right side of the page. As you answer each question, place an X in the box that
best describes how you have felt and conducted yourself over the past 6 months. Please give
this completed checklist to your healthcare professional to discuss during today’s
appointment.

Never

Patient Name

1. How often do you have trouble wrapping up the final details of a project,
once the challenging parts have been done?
2. How often do you have difficulty getting things in order when you have to do
a task that requires organization?

Inattentive

Screener alone
>4 total symptoms =
likely adult ADHD- investigate further

3. How often do you have problems remembering appointments or obligations?
4. When you have a task that requires a lot of thought, how often do you avoid
or delay getting started?
5. How often do you fidget or squirm with your hands or feet when you have
to sit down for a long time?

Hyperactive

6. How often do you feel overly active and compelled to do things, like you
were driven by a motor?

Part A
7. How often do you make careless mistakes when you have to work on a boring or
difficult project?
8. How often do you have difficulty keeping your attention when you are doing boring
or repetitive work?

Inattentive

>5 (of 9) Inattentive symptoms
(Questions 1-4; 7-11)
DSM 5 criteria for Inattention

9. How often do you have difficulty concentrating on what people say to you,
even when they are speaking to you directly?
10. How often do you misplace or have difficulty finding things at home or at work?
11. How often are you distracted by activity or noise around you?
12. How often do you leave your seat in meetings or other situations in which
you are expected to remain seated?
13. How often do you feel restless or fidgety?

Hyperactive

14. How often do you have difficulty unwinding and relaxing when you have time
to yourself?
15. How often do you find yourself talking too much when you are in social situations?

>5 (of 9) Hyperactive Symptoms
(Questions 5-6; 12-18)
DSM 5 criteria for Hyperactivity

16. When you’re in a conversation, how often do you find yourself finishing
the sentences of the people you are talking to, before they can finish
them themselves?
17. How often do you have difficulty waiting your turn in situations when
turn taking is required?
18. How often do you interrupt others when they are busy?

Symptoms within normal range
+
Normal Functioning
=

Full ADHD criteria previously met
+
Last 6 months, less than full ADHD criteria met
+
Functional Impairment (Social, academic, occupational)
=
Partial Remission

>5 Inattentive and/or
>5 hyperactive symptoms
+
Symptoms prior to age 12
+
Functional Impairment (social, academic, occupational)
+
> 2 settings (home, school, work, etc)
=
ADHD

Part B

!
Line of Clinical
Functional Remission
Significance
!
ADHD%ASRS!Symptom!Checklist!v1.1!is!copyrighted!by!the!World!Health!Organization!and!is!
available!for!unrestricted!use.!!
!
Kessler,!R.!C.,!Adler,!L.,!Ames,!M.,!Demler,!O.,!Faraone,!S.,!Hiripi,!E.,!Howes,!M.!J.,!Jin,!R.,!Secnik,!
K.,!Spencer,!T.,!Ustun,!T.!B.,!&!Walters,!E.!E.!(2005).!The!World!Health!Organization!Adult!
ADHD!Self%Report!Scale!(ASRS).!Psychological+Medicine,+35(2),!245%256.!!
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Appendix I
Revised ASRS Interpretation Guide
CODING'

F90.0:!Predominantly!Inattentive!
F90.1:!Predominantly!Hyperactive!
!
F90.2:!Combined!Type=!!
criteria!for!BOTH!inattentive!and!hyperactive!met!

Adult ADHD Self-Report Scale (ASRS-v1.1) Symptom Checklist

Very Often

Often

Sometimes

Rarely

Today’s Date

Please answer the questions below, rating yourself on each of the criteria shown using the
scale on the right side of the page. As you answer each question, place an X in the box that
best describes how you have felt and conducted yourself over the past 6 months. Please give
this completed checklist to your healthcare professional to discuss during today’s
appointment.

Never

Patient Name

1. How often do you have trouble wrapping up the final details of a project,
once the challenging parts have been done?
2. How often do you have difficulty getting things in order when you have to do
a task that requires organization?

Screener Alone
! 4 symptoms in Part A=
likely ADHD- investigate further

3. How often do you have problems remembering appointments or obligations?
4. When you have a task that requires a lot of thought, how often do you avoid
or delay getting started?
5. How often do you fidget or squirm with your hands or feet when you have
to sit down for a long time?
6. How often do you feel overly active and compelled to do things, like you
were driven by a motor?
Inattentive Symptoms:

! 5 (of 9) = DSM 5 criteria for inattention
Questions: 1-4; 7-11

Part A

7. How often do you make careless mistakes when you have to work on a boring or
difficult project?

8. How often do you have difficulty keeping your attention when you are doing boring
or repetitive work?
9. How often do you have difficulty concentrating on what people say to you,
even when they are speaking to you directly?
10. How often do you misplace or have difficulty finding things at home or at work?
11. How often are you distracted by activity or noise around you?
12. How often do you leave your seat in meetings or other situations in which
you are expected to remain seated?

Hyperactive Symptoms:
! 5 (of 9) = DSM 5 criteria for
hyperactivity

13. How often do you feel restless or fidgety?

Questions: 5, 6; 12-18

14. How often do you have difficulty unwinding and relaxing when you have time
to yourself?
15. How often do you find yourself talking too much when you are in social situations?
16. When you’re in a conversation, how often do you find yourself finishing
the sentences of the people you are talking to, before they can finish
them themselves?
17. How often do you have difficulty waiting your turn in situations when
turn taking is required?
18. How often do you interrupt others when they are busy?

Part B

Symptoms within normal range
+
Normal Functioning
=
!
Functional
Remission

!
!

Full ADHD criteria previously met
+
Last 6 months, less than full ADHD criteria met
+
Functional Impairment (social, academic, occupational)
=
Partial Remission

Line of
Clinical Significance

! 5 inattentive and/or ! 5 hyperactive symptoms
+
Symptoms prior to age 12
+
Functional Impairment (social, academic, occupational)
+
!2 settings (home, school, work, etc)
=
Adult ADHD

!

!
ADHD%ASRS!Symptom!Checklist!v1.1!is!copyrighted!by!the!World!Health!Organization!and!is!available!for!
unrestricted!use.!!
!
Kessler,!R.!C.,!Adler,!L.,!Ames,!M.,!Demler,!O.,!Faraone,!S.,!Hiripi,!E.,!Howes,!M.!J.,!Jin,!R.,!Secnik,!K.,!Spencer,!T.,!
Ustun,!T.!B.,!&!Walters,!E.!E.!(2005).!The!World!Health!Organization!Adult!ADHD!Self%Report!Scale!(ASRS).!
Psychological+Medicine,+35(2),!245%256.!!
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Appendix J
Provider Survey Cover Letter
Dear Providers,
My name is Danielle Miller and I am a Doctor of Nursing Practice (DNP) student through
Grand Valley State University. I am working with Dr. XXXX MD to conduct a quality
improvement project for the care of adults with Attention Deficit/Hyperactivity Disorder
(ADHD). The goal of this project is to implement the use of validated symptom scale and
determine how the use of the scale may affect clinical practice surrounding the care of adults
with ADHD.
As a provider in this office, your participation is valued for the success of the project and
improvement of care we provide to patients with ADHD. This letter is an invitation to
participate in a brief survey to assist me in the quality improvement process. Participation in
this survey is voluntary and responses will remain anonymous.
Survey responses will be collected anonymously and no information that will identify you as
an individual will be collected. Survey results will be reported only as the collective provider
aggregate. The information collected will be used only for the purposes of this project and
will not be reported elsewhere at any time.
Benefits of participation in this survey include improved understanding of the provider
approach to ADHD care in the primary care setting. The information will be used to improve
education and provide resources for use in the care of adults with ADHD.
If you have any questions regarding this project, please feel free to contact me in person or via
email at dobbsd@mail.gvsu.edu.
Sincerely,
Danielle Miller BSN, RN
Grand Valley State University
DNP Student
dobbsd@mail.gvsu.edu
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Appendix K
Pre-implementation Provider Survey
The goal of this project is to implement the use of validated symptom scale and determine how the use of the scale may affect
clinical practice surrounding the care of adults with ADHD. As a provider in this office, your participation is valuable for the
success of the project and improvement of care we provide to patients with ADHD. By completion of the survey, a waiver of
consent is implied. Participation in this survey is voluntary and responses will remain anonymous.
Please complete this survey and return to Danielle Miller or Dr. XXXX MD by Wednesday, November 14.
Please answer these questions/statements regarding care of the adult with ADHD…

1.   I would rate my knowledge of adult ADHD as _______
a.  

Very low

b. Low

c. Moderate

d. High

e. Very high

c. Sometimes

d. Usually

e. Always

2.   I routinely use a validated symptom rating scale.
a.  

Never

b. Rarely

3.   I think a symptom scale is ________ helpful in the management or treatment of adult ADHD
a.  

Never

b. Rarely

c. Sometimes

d. Usually

e. Always

d. Usually

e. Always

d. High

e. Very high

d. High

e. Very high

d. Usually

e. Always

4.   I know who to ask if I have a question regarding ADHD management.
a.  

Never

b. Rarely

c. Sometimes

5.   My confidence in medication management of an adult with ADHD is:
a.  

Very low

b. Low

c. Moderate

6.   My understanding of medications and dosing for an adult with ADHD is
a.  

Very low

b. Low

c. Moderate

7.   Documentation of ADHD symptoms and management plan is easy.
a.  

Never

b. Rarely

c. Sometimes

8.   I routinely discuss nonpharmacological treatment options with my adult patients with ADHD.
a.  

Never

b. Rarely

c. Sometimes

d. Usually

e. Always

9.   I offer information on community resources, support groups, or professional support to adults with ADHD.
a.  

Never

b. Rarely

c. Sometimes

d. Usually

e. Always

10.   List any questions or concerns regarding ADHD care.
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Appendix L
Post-implementation Provider Survey
The goal of this project was to implement the use of validated symptom scale and determine how the use of the scale may
affect clinical practice surrounding the care of adults with ADHD. As a provider in this office, your participation is valuable
for the success of the project and improvement of care we provide to patients with ADHD. By completion of the survey, a
waiver of consent is implied. Participation in this survey is voluntary and responses will remain anonymous.
Please complete this survey and return to Danielle Miller or Dr. XXXX MD by Thursday, February 28.
Please answer these questions/statements regarding care of the adult with ADHD…

1.   I would rate my knowledge of adult ADHD as _______
a.  

Very low

b. Low

c. Moderate

d. High

e. Very high

c. Sometimes

d. Usually

e. Always

2.   I routinely use a validated symptom rating scale.
a.  

Never

b. Rarely

3.   I think a symptom scale is ________ helpful in the management or treatment of adult ADHD
a.  

Never

b. Rarely

c. Sometimes

d. Usually

e. Always

d. Usually

e. Always

d. High

e. Very high

d. High

e. Very high

d. Usually

e. Always

4.   I know who to ask if I have a question regarding ADHD management.
a.  

Never

b. Rarely

c. Sometimes

5.   My confidence in medication management of an adult with ADHD is:
a.  

Very low

b. Low

c. Moderate

6.   My understanding of medications and dosing for an adult with ADHD
a.  

Very low

b. Low

c. Moderate

7.   Documentation of ADHD symptoms and management plan is easy.
a.  

Never

b. Rarely

c. Sometimes

8.   I routinely discuss nonpharmacological treatment options with my adult patients with ADHD.
a.  

Never

b. Rarely

c. Sometimes

d. Usually

e. Always

9.   I offer information on community resources, support groups, or professional support to adults with ADHD.
a.  

Never

b. Rarely

c. Sometimes

d. Usually

e. Always

10: What are your recommendations for improved delivery of care for adults with ADHD?
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Appendix M
Provider SBAR
Situation:
•  

Currently XXXX does not have a validated symptom scale to use in assessing adults with Attention
Deficit/Hyperactivity Disorder (ADHD). ADHD is considered a chronic condition, as such should be routinely
monitored with a validated measurement tool.
Background:
•  

Rating scales are helpful for assessing whether a patient meets Diagnostic and Statistical Manual of Mental
Disorders (DSM) criteria for adult ADHD diagnosis and for assessing current symptoms (Adler & Cohen, 2004).
•   Guidelines recommend utilizing a validated symptom assessment tool in evaluation of adults with ADHD
o   International Guidelines:
§   National Institute for Health and Care Excellence (NICE), 2018
§   Canadian ADHD Resource Alliance (CADDRA), 2018
o   National Guidelines and Organizations:
§   American Academy of Pediatrics, 2011
§   Children and Adults with Attention-Deficit/Hyperactivity Disorder (CHADD), 2018
o   State-level
§   Michigan Quality Improvement Consortium, 2017
o   Insurances
§   Blue Cross Blue Shield Complete of Michigan
§   Optima Health
Assessment:
•  
•  
•  
•  
•  

•  

In pediatric patients, use of validated ADHD symptom scales is considered the standard of care and is routinely
used. In the adult population, the use of a validated symptom scale is considered part of the standard of care,
however is not consistently used for symptom assessment.
Diagnosis of ADHD is based on childhood onset of symptoms, functional impairment, and current symptoms
(Adler & Cohen, 2004).
The Adult ADHD Self-Report Scale (ASRS-v1.1) Symptom Checklist was originally developed by a workgroup on
adult ADHD and is available through the World Health Organization (Adler & Cohen, 2004). The ASRS has been
validated using the National Comorbidity Survey and in adult ADHD populations (Adler & Cohen, 2004).
Consistent use of the ASRS symptom checklist can allow the provider to quickly assess if ADHD symptoms are
under control and allow the provider to monitor treatment response.
The 18-item ASRS Symptom v1.1 Checklist corresponds to nine hyperactive symptoms and nine inattentive
symptoms which correspond to both the DSM IV and V diagnostic criteria for adult ADHD (Silverstein et al.,
2018).
o   Utilization of the full ASRS can improve classification of ADHD among true cases and is useful in
charting clinical improvement among adults with ADHD receiving treatment (Kessler et al., 2005).
The first six questions on the ASRS is useful in screening for possible ADHD in cases where diagnosis has not yet
been made (Kessler et al., 2005).

Recommendation:
MAs/RNs/Flow Staff:
•   Ask patient to complete the ASRS (may be sent in chart prep or when patient arrives)
•   Score and share results with provider
•   Scan and Upload to chart
Providers:
•  
•  
•  

  

Ensure documentation of ASRS has been uploaded to chart for future reference.
Evaluate symptoms on ASRS and discuss with patient, intervene as appropriate.
Consider referencing pharmacological and non-pharmacological intervention guides for adult ADHD as needed.
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Appendix N
ASRS Medical Assistant Letter/Education
Dear Registered Nurses, Medical Assistants, and Flow Staff,
My name is Danielle Miller and I am a Doctor of Nursing Practice (DNP) student through Grand
Valley State University. I am working with Dr. XXXX MD to conduct a quality improvement project
for the care of adults with Attention Deficit/Hyperactivity Disorder (ADHD). The goal of this project
is to implement the use of validated symptom scale and determine how the use of the scale may affect
clinical practice surrounding the care of adults with ADHD.
As a member of the office team, your participation is valued for the success of the project and
improvement of care we provide to patients with ADHD. We plan to assess all adult patients with an
ADHD diagnosis regardless of reason for visit for the project period starting November 12, 2018. We
will use the Adult ADHD Symptom Checklist with patients coming in for initial evaluation of possible
ADHD, ADHD follow-up, and annual physicals of patients with ADHD.
The workflow will be as follows:
1. Chart Prep, adult patient noted to have ADHD on the problem list or be on a stimulant prescription
2. Include copy of ASRS v1.1 in chart prep packet- copies of ASRS v1.1 to be located at each desk
3. Adult with ADHD arrives
4. During Intake, if “Reason for Visit” is ADHD evaluation, follow up, or med review OR if patient is
here for a physical or any other reason and has ADHD noted on the problem list- ask patient to
complete ASRS v1.1
5. Score ASRS symptoms- Instructions attached
6. Record inattentive and hyperactive symptoms per ASRS in HPI and discuss with provider
7. Scan and upload ASRS v1.1 to chart
1.   On patient’s facesheet, click “add document” link
2.   Complete first page as usual, select the document class/subclass and choose file to be
added, click create document
3.   The system will upload the document in DATA ENTRY status
4.   Document Type: Select “Document Type not listed” and type “Adult ADHD rating
scale” in the internal note
5.   Complete data entry by selecting data entry completed and click save
If you have any questions regarding this project, please feel free to contact me in person or via email at
dobbsd@mail.gvsu.edu.
Sincerely,
Danielle Miller BSN, RN
Grand Valley State University
DNP Student
dobbsd@mail.gvsu.edu
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Appendix O
Revised ASRS Medical Assistant Letter/Education
Dear Registered Nurses, Medical Assistants, and Flow Staff,
My name is Danielle Miller and I am a Doctor of Nursing Practice (DNP) student through Grand
Valley State University. I am working with Dr. XXXX MD to conduct a quality improvement project
for the care of adults with Attention Deficit/Hyperactivity Disorder (ADHD). The goal of this project
is to implement the use of validated symptom scale and determine how the use of the scale may affect
clinical practice surrounding the care of adults with ADHD.
As a member of the office team, your participation is valued for the success of the project and
improvement of care we provide to patients with ADHD. We plan to assess all adult patients with an
ADHD diagnosis regardless of reason for visit for the project period starting December 3, 2018. We
will use the Adult ADHD Symptom Checklist (ASRS) with patients coming in for initial evaluation
of possible ADHD, ADHD follow-up, and annual physicals of patients with ADHD.
The workflow will be as follows:
Chart Prep:
•   IF adult has ADHD on the problem list or on a stimulant prescription
•   THEN: include copy of ASRS v1.1 in chart prep packet
Intake for Adults with ADHD:
•   “Reason for Visit” is ADHD evaluation, follow up, or med review OR if patient is here for a
physical or any other reason and has ADHD noted on the problem list- ask patient to complete
ASRS v1.1
•   Score ASRS symptoms- Instructions attached
•   Record inattentive and hyperactive symptoms per ASRS in HPI and discuss with provider
•   Scan and upload ASRS v1.1 to chart
6.   Patient’s Quickview, click Clinicals tab
7.   Select Print Document Barcode
8.   Select “Encounter Document” and choose “Health History Questionnaire”
9.   Enter the Encounter Date
10.   For status: Change to “close” unless the provider needs to evaluate
11.   Add Internal Note: ADHD Self Report or ASRS
12.   Complete data entry by selecting data entry completed and click save
If you have any questions regarding this project, please feel free to contact me in person or via email at
dobbsd@mail.gvsu.edu.
Sincerely,
Danielle Miller BSN, RN
Grand Valley State University
DNP Student
dobbsd@mail.gvsu.edu
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Appendix P
ADHD Quality Improvement Education Poster

ADULT ADHD SYMPTOM CHECKLIST

OBJECTIVE

SITUATION
Validated symptom scales are not being used to assess adults
with ADHD and could help providers assess current symptoms
and whether the patient’s treatment has been helping.
All team members are needed

The goal of this project is to implement
the use of validated symptom scale
and determine how the use of the
scale may affect clinical practice
surrounding the care of adults with
ADHD.

BACKGROUND
Symptom Rating Scales are Useful and Quick
•!

Takes less than 5 minutes

•!

Quickly assess inattentive vs. hyperactive symptoms

•!

Can be used to assess treatment progress

Recommended by guidelines for ADHD
•!

National Institute for Health and Care (NICE), 2018
from UK;

•!

Canadian ADHD Resource Alliance (CADDRA), 2018;

•!

American Academy of Pediatrics (2011);

•!

Children and Adults with Attention
Deficit/Hyperactivity Disorder (CHADD), 2018;

•!

Michigan Quality Improvement Consortium (2017);

•!

Many insurance providers.

RECOMMENDATION
MAs/RNs Flow Staff:
•!

Ask patient to complete the ASRS
(may be sent in chart prep or when
patient arrives)

•!

Score and Share results with provider

•!

Scan and Upload to chart

Providers:
•!

Evaluate symptoms on ASRS and
discuss with patient, intervene as
appropriate

•!

Ensure documentation of ASRS has
been uploaded to chart for future
reference

•!

Please contact Danielle Miller DNP
student or Dr. XXXX MD

ASSESSMENT
Already Used in Pediatrics
Validated ADHD symptom scales are commonly used in
pediatrics
Adult ADHD ASRS Symptom Checklist
•!
•!
•!

Developed by the World Health Organization
Inattentive and hyperactive symptoms correspond to
DSM criteria
Assess current symptoms and treatment response

QUESTIONS

Email: dobbsd@mail.gvsu.edu
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Appendix Q
Provider Medication Guide

Active'Ingredient'

Drug'Name'

Dosages'

Duration'
of'effect'

Starting'dose'

Titration'

Maximum'dose'

5,)10,)15,)20,)
25,)30)mg)
12.5,)25,)37.5,)
50)mg)
18,)27,)36,)54)
mg)
10,)20,)30,)40,)
50,)60)mg)

8B10)hrs)

20)mg/day)in)
the)am)
12.5)mg)to)25)
mg)daily)
18)or)36)mg)in)
the)am)
20)mg)once)
daily)

Increase)by)10)mg)
weekly)
Increase)by)12.5)mg)
weekly)
Increase)by)18)mg)
weekly)
Increase)by)10)mg)
increments)weekly)

60)mg/day)

10,)20,)30,)40,)
50,)60,)70)mg)

12B14)hr)

30mg)in)the)
am)

Increase)by)10)to)20)
mg)weekly)

70)mg/day)

5,)7.5,)10,)
12.5,)15,)20,)
30)mg)
5,)10,)20)mg)

4B)6)hrs)

5)mg)1B2)times)
daily)

Increase)by)5)mg)
weekly)

40B60)mg/daily))

3B5)hrs)

5)mg)BID,)
before)
breakfast)and)
lunch)

Increase)by)5B10)mg)
at)weekly)intervals)

60)mg/day)in)divided)
doses)

24)hrs)

40)mg/day)

Increase)every)7B14)
days)to)60)mg,)then)
to)80)mg))

Lesser)of:)100)mg/day)
or)1.4)mg/kg/day)

12)hrs)

100)mg)daily)

Increase)to)100)mg)
BID)after)several)
weeks;)may)increase)
dose)150)mg)BID,)
then)200)mg)BID)with)
several)weeks)
between)titrations)
After)several)weeks,)
may)increase)to)300)
mg)daily)
Increase)by)1)
mg/week)

200)mg)BID)

Long:acting'Psychostimulants'*Preferred'
Extended)release))
Mixed)salts)of)amphetamine)
(dextramphetamine/Levoampheta
mine))
ExtendedBRelease)
Methylphenidate)
Methylphenidate)

Lisdexamfetamine)
Short:acting'Psychostimulants''
Mixed)salts)of)amphetamine)
(dextroamphetamine/levoamphet
amine))
Methylphenidate)

Adderall)
XR/generic)
Mydayis)
Concerta)
Extended)
release)
capsule)
)
Vyvanse)

Adderall/gen
eric)
Ritalin)IR)

Non:stimulants'(may'take'weeks'to'see'clinical'efficacy))
Atomoxetine)
Strattera)
10,)18,)25,)40,)
60,)80,)100)
mg)
Off:Label'Options'
Bupropion)
Wellbutrin)
100,)150,)200)
SR)
mg)

Guanfacine)extended)release)

Up)to)16)
hrs)
10B12)hr)
6B8)hrs)

Wellbutrin)
XL)

150,)300)mg)

24)hr)

150)mg)daily)

Intuniv)XR)

1,)2,)3,)4)mg)

24)hr)

1)mg)once)
daily)

1st'line'recommendation:'Long:acting'psychostimulants'
o! Single)dosage)maintains)privacy)and)reduces)stigma)
(school,)work,)social)situation)))
o! Increases)compliance)and)convenience)
o! Improved)symptom)control)related)to)pharmacokinetic)
profile)(fewer)ups)and)downs))
o! Reduced)risk)of)diversion)
Amphetamine'vs.'methylphenidate?'
o! Both)block)reuptake)of)dopamine)and)norepinephrine,)
but)mechanism)of)action)is)different)
o! Affects)individuals)differently)
o! If)one)does)not)work)well,)try)the)other.)There)is)no)
preferred)order)for)medication)trial.))
Atomoxetine'
o! Selective)norepinephrine)reuptake)inhibitor)
o! Takes)longer)to)produce)response)than)stimulants)
Bupropion'

50)mg/day)
72)mg/day)
60)mg/day)

450)mg)daily)

MonotherapyB)up)to)7)
mg/day)
Adjunctive)with)
psychostimulant:)up)to)
4)mg/day)

Efficacious)in)reducing)symptoms)in)for)adults)with)
ADHD)
Antidepressant)with)mixed)catecholaminergic)effects)
Also)efficacious)for)depression)and)smoking)cessation)
and)may)be)appropriate)for)adults)with)ADHD)and)one)
of)these)conditions)
Guanfacine'extended'release'
o! Approved)and)effective)for)children,)not)FDA)approved)
for)adult)ADHD)
o! Selective)alphaB2)adrenoreceptor)agonist,)theorized)to)
improve)delayBrelated)firing)of)prefrontal)cortex)
neurons
o!
o!
o!

American)Academy)of)Pediatrics.)(2011).)Clinical)practice)guideline)ADHD:)Clinical)practice)guideline)for)the)diagnosis,)evaluation,)and)treatment)of)AttentionBDeficit/Hyperactivity)Disorder)in)children)and)adolescents.)Pediatrics,)
125(5),)1007B1022.)Doi:)10.1542/peds.2011B2654)
Bukstein,)O.)(2018).)Pharmacotherapy)for)adult)attention)deficit)hyperactivity)disorder.)UpToDate.)Retrieved)October)14,)2018.)
Canadian)ADHD)Resource)Alliance)(CADDRA).)(2018).)Canadian)ADHD)practice)Guidelines)(4th)ed.).))Toronto,)ON.)Retrieved)from)https://www.caddra.ca)
Children)and)Adults)with)AttentionBDeficit/Hyperactivity)Disorder)(CHADD).)(2018).)Medication)management.)Retrieved)from)http://www.chadd.org/UnderstandingBADHD/ForBAdults/Treatment/MedicationBManagement.aspx)
National)Institute)for)Health)and)Care)Excellence)(NICE).)(2018).)Attention)deficit)hyperactivity)disorder:)Diagnosis)and)management.)Retrieved)from)https://www.nice.org.uk/guidance/ng87)
Optima)Health.)(2016).)Diagnosis)and)management)of)ADHD)in)adults.)Retrieved)from)https://www.optimahealth.com/documents/clinicalBguidelines/adhdBadults.pdf)
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Appendix R
Provider Non-Pharmacological Interventions Guide

ADHD$Non(Pharmacological$Interventions$and$Resources$
$
!! Although!stimulants!and!pharmacological!agents!are!first!line!treatment!in!ADHD,!education!and!nonBpharmacological!
treatments!play!an!important!role.!
!
Psychoeducation$
!! What$does$my$patient$know$about$ADHD??!
o! Biological!origins:!Neurodevelopmental!condition!with!symptoms!from!mild!to!severe!
o! Occurs!throughout!lifespan!
!! Dispelling$Myths!
o! ADHD!is!not!real,!patients!are!lazy!and!looking!for!excuses!
"! There!are!numerous!physical!differences!in!the!brain!structure!of!patients!with!ADHD.!ADHD!tends!to!run!
in!families!and!has!significant!genetic!components.!ADHD!results!in!social,!academic,!emotional,!and!work!
functional!problems.!
o! ADHD!is!a!disorder!of!childhood!
"! ADHD!persists!into!adolescence!in!50B80%!of!cases!and!into!adulthood!inn!35B65%!of!cases!
o! ADHD!is!overBdiagnosed!
"! Increasing!diagnostic!rates!could!be!attributed!to!improved!recognition,!decreased!stigma,!and!more!
treatment!options.!
o! ADHD!caused!by!poor!parenting!
"! Main!causes!of!ADHD:!genetic!and!neurologic!factors!(complications!during!pregnancy/birth,!brain!
damage,!toxins,!etc)!
o! Girls!have!lower!rates!and!severity!than!boys!
"! Girls/women!have!substantial!impairments!that!are!of!a!similar!rate!to!boys.!
"! Diagnostic!rate!is!higher!for!boys!than!girls,!but!prevalence!by!adulthood!is!nearly!the!same.!
!! Educate!
o! Importance!of!combining!medications!with!psychosocial!interventions!
o! Risks!and!benefits!of!treatment!
!! Promote$Health!
o! Regular!exercise,!good!sleep!hygiene,!and!nutrition!
!! Give$Resources!
o! Websites!
"! Attitude!Magazine!for!People!with!ADHD;!http://attitudemag.com!
"! AttentionBDeficit!Disorder!Association!(ADDA);!https://add.org!
"! Children!and!Adults!with!AttentionBDeficit/Hyperactivity!Disorder!(CHADD);!http://www.chadd.org!
"! National!Institute!of!Mental!Health!(NIMH);!https://www.nimh.nih.gov/health/topics/attentionBdeficitB
hyperactivityBdisorderBadhd/index.shtml!
o! Books!
"! Adler,!L.!&!Florence,!M.!(2006).!Scattered(Minds:(Hope(and(Help(for(Adults(with(ADHD.!New!York:!Putnam.!
"! Barkley,!R.!A.!(2010).!Taking(Charge(of(Adult(ADHD.!New!York:!Guilford!Press.!
"! Barkley,!R.!A.,!Murphy,!K.!R.,!&!Fischer,!M.!(2008).!ADHD(in(Adults:(What(the(Science(Says.(New!York:!
Guilford!Publications!
"! Brown,!T.!E.!(2005).!Attention(Deficit(Disorder:(The(Unfocused(Mind(in(Children(and(Adults.(New!Haven,!
CT:!Yale!University!Press.!
"! Brown,!T.!E.!(2014).!Smart(but(Stuck.!San!Francisco,!CA:!John!Wiley!&!Sons,!Inc.!
"! Hallowell,!E.!M.,!&!Ratey,!J.!J.!(2011).!Driven(to(Distraction((Revised):(Recognizing(and(Coping(with(
Attention(Deficit(Disorder.(New!York:!Anchor!Books.!
"! Kelly,!K.,!&!Ramundo,!P.!(2006).!You(Mean(I’m(Not(Lazy,(Stupid(or(Crazy?!:(The(Classic(SelfOHelp(Book(for(
Adults(with(Attention(Deficit(Disorder.!New!York:!Simon!&!Schuster.!
"! Surman,!C.,!Bilkey,!T.,!Weintraub,!K.!(2013).!Fast(Minds:(How(to(Thrive(if(you(have(ADHD((Or(Think(You(
Might).(New!York:!Penguin!Groups.!
o! Community$Resources!
"! CHADD!ADHD!Specialist!Help!Line:!1B800B233B4050!MondayBFriday!1pB5pm!Eastern!Time!
"! CHADD!Online!Community:!http://www.chadd.org/Support/TipsBandBResources.aspx!

!

American!Academy!of!Pediatrics.!(2011).!Clinical!practice!guideline!ADHD:!Clinical!practice!guideline!for!the!diagnosis,!evaluation,!and!treatment!of!AttentionBDeficit/Hyperactivity!Disorder!in!children!and!adolescents.!Pediatrics,!125(5),!1007B1022.!Doi:!
10.1542/peds.2011B2654!
Canadian!ADHD!Resource!Alliance!(CADDRA).!(2018).!Canadian!ADHD!practice!Guidelines!(4th!ed.).!!Toronto,!ON.!Retrieved!from!https://www.caddra.ca!
Children!and!Adults!with!AttentionBDeficit/Hyperactivity!Disorder!(CHADD).!(2018).!Myths!and!misunderstandings.!Retrieved!from!http://www.chadd.org/understandingBadhd/aboutBadhd/mythsBandBmisunderstandings.aspx!
National!Institute!for!Health!and!Care!Excellence!(NICE).!(2018).!Attention!deficit!hyperactivity!disorder:!Diagnosis!and!management.!Retrieved!from!https://www.nice.org.uk/guidance/ng87!
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Objectives*for*Presentation
1.
2.
3.
4.

Review the clinical problem
Review organizational assessment
Review evidence for project and project plan
Review project results and sustainability

Introduction
• Attention Deficit/Hyperactivity Disorder (ADHD) is
common and often managed in the primary care setting.
– Prevalence: 1-7% worldwide
– Symptoms of inattention, hyperactivity, and
impulsivity lead to functional impairments which
affect an individual’s education, family/social life,
and work.
• Historically thought of as a disorder of childhood, now
known as a chronic condition which affects adults
(Morstedt, Corbisiero, Bitto, & Stieglitz, 2015)
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The$Problem
• Deficits caused by ADHD may lead to longterm problems and decreased function of
patients with ADHD and their families
• Diagnosis and treatment is difficult
– Symptom presentation and functional deficits vary
widely
– Symptoms often overlap with other comorbid
psychological problems
(Morstedt et al., 2015)

Organizational Assessment

3
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Framework:*Burke*&*Litwin
• Transformational variables
–
–
–
–
–

External environment
Mission & Strategy
Leadership
Organizational culture
Individual/organizational performance

• Transactional factors
–
–
–
–
–
–
–

Structure
Management practices
Systems
Work-unit climate
Individual skills
Motivation
Individual needs/values

(Burke & Litwin, 1992)

Current'state'of'site:'ADHD'practices
• Chart Review
– 238 adult patients with ADHD diagnosis in 3 months
– 35% did not have any ADHD symptoms recorded in History of
Present Illness

• Shadowing/Interviewing
– Pediatric providers routinely use Conner’s Parent/Teacher Rating
Scales to evaluate/document pediatric ADHD
– No screening/measurement tools were used or available to use
for adult patients with ADHD
– Inconsistency in provider practices for evaluation,
documentation, and treatment
– Interview with adult provider: management of ADHD in adults
is largely “gestalt”

4
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IRB$Approval
NOTICE OF CLINICAL QUALITY IMPROVEMENT MEASUREMENT DESIGNATION
DATE:

October 29, 2018

TO:
FROM:
STUDY TITLE:
REFERENCE #:
SUBMISSION TYPE:

Amy Manderscheid
HRRC
Adult Attention Deficit/Hyperactivity Disorder Quality Improvement Project
19-122-H
HRRC Research Determination Submission

ACTION:
EFFECTIVE DATE:
REVIEW TYPE:

Not Research
October 29, 2018
Administrative Review

Thank you for your submission of materials for your planned scholarly activity. It has been determined
that this project does not meet the definition of research* according to current federal regulations. The
project, therefore, does not require further review and approval by the Human Research Review
Committee (HRRC).
A summary of the reviewed project and determination is as follows:
The goal of this quality improvement project is to increase the frequency that providers use a validated
ADHD symptom scale in the treatment and diagnosis of ADHD in primary care. While this is a systematic
investigation, it is not designed to contribute to generalizable knowledge. Therefore, this project does not
meet the federal definition of research and IRB oversight is not required.
An archived record of this determination form can be found in IRBManager from the Dashboard by
clicking the “_ xForms” link under the “My Documents & Forms” menu.
If you have any questions, please contact the Office of Research Compliance and Integrity at (616) 3313197 or rci@gvsu.edu. Please include your study title and study number in all correspondence with our
office.

To:

Danielle (Dobbs) Miller
4761 Shade Leaf Lane SE
Grand Rapids, MI 49546

Re:

IRB# 18-1025-4
Adult Attention Deficit/Hyperactivity Disorder Quality Improvement Project

Date:

10/26/2018

This is to inform you that the Mercy Health Regional Institutional Review Board (IRB) has
reviewed your proposed research project entitled "Adult Attention Deficit/Hyperactivity
Disorder Quality Improvement Project". The IRB has determined that your proposed project
is not considered human subjects research. The purpose and objective of the proposed
project meets the definition of a clinical quality improvement measurement. All
publications referring to the proposed project should include the following statement:
"This project was undertaken as a Clinical Quality Improvement Initiative at Mercy Health
and, as such, was not formally supervised by the Mercy Health Regional Institutional Review
Board per their policies."
The IRB requests careful consideration of all future activities using the data that has been
proposed to be collected and used "in order to assess resulting changes in ADHD
management of adults following the implementation of a validated ADHD symptom scale
and toolkit."
The IRB requests resubmission of the proposed project if there is a change in the current
clinical quality improvement measurement design that includes testing hypothesis, asking
a research question, following a research design or involves overriding standard clinical
decision making and care.

Sincerely,
Office of Research Compliance and Integrity

Please feel free to contact me if you have any questions regarding this matter.

*Research is a systematic investigation, including research development, testing and evaluation, designed to develop
or contribute to generalizable knowledge (45 CFR 46.102 (d)).

Tiffany VanTilburg, CIC
Office of the IRB

Human subject means a living individual about whom an investigator (whether professional or student) conducting
research obtains: data through intervention or interaction with the individual, or identifiable private information (45

Copy: File

CFR 46.102 (f)).
Scholarly activities that are not covered under the Code of Federal Regulations should not be described or referred to
as research in materials to participants, sponsors or in dissemination of findings.

Institutional Review Board - 200 Jefferson Ave. SE – Grand Rapids, MI 49503 - P: 616.685.6198

!
Office of Research Compliance and Integrity | 1 Campus Drive | 049 James H Zumberge Hall | Allendale, MI 49401
Ph 616.331.3197 | rci@gvsu.edu | www.gvsu.edu/rci

Stakeholders
• Staff members
– Providers
– Assistive staff (RNs, MAs)

• Organizational leaders
– Quality Improvement
– IRB

• Adult patients with ADHD
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SWOT

Strengths

Weaknesses

•

Opportunity for standardized care

•

•

Team-based environment

•

•
Validated adult ADHD Symptom
Checklist (ASRS v1.1) is freely available
for use.

•

Improve provider knowledge and
comfort with diagnosis and treatment of
ADHD

•

Staff schedules predominately include
routine screenings and quality measures,
may be overwhelming to change practice

•

Improved documentation and
collaboration between care providers

•

Lack of buy-in of organizational leaders,
and office staff could severely limit
quality improvement opportunities and
sustainability of the intervention.

No current standard of practice
surrounding ADHD care
Documentation of ADHD symptoms is
not simple in current charting system

Opportunities

Threats

Clinical'Practice'Question
• Does implementation of the Adult ADHD SelfReport Scale (ASRS v1.1) Symptom Checklist
and ADHD toolkit affect clinical practice
surrounding the assessment and treatment of
ADHD?

6
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Literature Review
Purpose:
Identify areas where evidence based practice for ADHD may better inform care
in primary care
Aims:
1. What tools can aid ADHD diagnosis, treatment, and management in adults
2. What clinical guidelines are available to inform care of adults with ADHD

Review&Method
• Preferred Reporting Items for Systematic Reviews and MetaAnalyses (PRISMA)
• Databases:
– CINAHL
– PubMed
– PsychINFO

(Moher, Liberati, Tetzlaff, Altman, & PRISMA Group, 2009).

• Key Words:
– Attention Deficit
Hyperactivity Disorder or
ADHD
– diagnosis and treatment
– quality improvement
– collaborative care
– primary care

– management

7
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PRISMA'Figure

Summary'of'Literature'Review
• Literature review resulted in area of focus and
support for intervention in primary care setting
• Articles reviewed again for commonly used tools
for assessment of symptoms in adult ADHD
– Adult ADHD Self-Report Scale (ASRS-v1.1)
Symptom Checklist
– Conner’s Adult ADHD rating scale
– Brown ADHD Scale (BADDS)
– Barkley Adult ADHD Rating Scale (BAARS-IV)
– Wender Utah Rating Scale

8
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Evidence(for(Project
• Adult ADHD Self-Report (ASRS-v1.1) Symptom Checklist
– Widely used symptom scale
– Freely available
– 18-items, 5 minutes to complete
– Based on DSM-IV criteria
• Adult ADHD Symptoms have not changed from DSMIV to DSM-V
• Number of inattentive or hyperactive symptoms
required decreased from 6 to 5 in adults.
• Other tools were cost prohibitive or too long for use in primary
care
(National Comorbidity Survey, n.d.; Kessler et al., 2005; Ustun et al., 2017)

Chronic(Care(Model
• American Academy of Pediatrics (2011) recognizes ADHD as a
chronic condition persisting into adulthood
• Appropriate management: goal directed treatment, patient education,
complementary resources
• Chronic Care Model can serve as framework for ADHD care for
improved health care services and outcomes
–
–
–
–
–

Community Resources
Self Management support
Delivery of medical services
Decision support
Clinical information systems

(Culpepper & Fried, 2013)

9
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Project(Plan

Project(Purpose(&(Objectives
Goal: Implement use of the Adult ADHD Self-Report Scale (ASRS V-1.1)
Symptom Checklist and ADHD toolkit, increase provider use of a validated
symptom scale, and evaluate changes in clinical practices surrounding the care
of adults with ADHD.
Objectives for quality improvement are:
• To increase the use of ADHD assessment and symptom scales by providers
within a primary care clinic.
• To assess provider knowledge and clinical practices with the diagnosis,
treatment, and management of ADHD.
• To assess provider practices of medication prescription for the treatment of
ADHD.
• To assess whether use of ADHD symptom scale and toolkit increases
adherence to evidence based practices of managing ADHD.

10
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Design
• Quality Improvement Project
– Retrospective and prospective data

• Project Implementation: Model for Improvement,
Plan-Do-Study-Act design
– Pre-implementation: IRB approval, review existing
medical records, and provider surveys
– Implementation: ASRS v1.1 and ADHD toolkit
• Initially with 3 of 12 providers + teams
• Secondly, with remaining 9 providers + teams

– Post-implementation: review of patient records,
provider survey

Setting'&'Participants
• Where: Physician Partners-Downtown location
• Who:
– Providers (physicians, NPs, PAs)
– Staff (RNs, MAs)
– Patients

11
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Model&for&Improvement:
• Plan-Do-Study-Act

(Langley et al., 2009)

Process'flow'for'ADHD'toolkit
• Staff
– Toolkit:
•
•
•
•

Adult ADHD Self-Report Scale (ASRS v1.1) Symptom Checklist
ASRS Interpretation Guide
ASRS Flow Staff Letter/Education
ADHD Quality Improvement Education Poster

– Plan:
• Chart preparation: if patient has adult ADHD- included ASRS in
chart preparation packet
• Intake: Collect completed ASRS from chart preparation or ask
patient to complete ASRS at office
• Scoring and provide to provider
• Upload to patient’s chart for the visit

12
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Process'flow'for'ADHD'toolkit
• Providers
– Toolkit:
•
•
•
•
•

Adult ADHD Self-Report Scale (ASRS v1.1) Symptom Checklist
ASRS Interpretation Guide
Provider SBAR
Provider Medication Guide
Provider Non-pharmacological intervention guide

– Plan:
• Ensure patient has completed ASRS for each adult with ADHD or
suspected ADHD
• Assess reported symptoms and incorporate into clinical assessment
• Provide treatment per clinical judgement
• Ensure ASRS is uploaded to patient’s chart for the visit

Evaluation*&*Measures
Pre-/Post-measures
– Surveys: Provider knowledge and clinical practices
• November 2018; January 2019

– Chart Review: pre and post implementation
• 5 weeks pre-implementation: November 2018
• 5 weeks post-implementation January 7th- February 8, 2019

– Observation: Implementation process/workflow
• Initial 3 providers: Weeks of November 12, 19, 26, 2018
• Remaining 9 providers: December 3, 2018

13

  

  

  

101

FINAL DEFENSE
  
  

  

  
4/2/19

Measures
•
•
•
•
•
•
•
•
•
•

Gender
Age
Race
Diagnosis code
Current visit type
Last office visit for ADHD symptom evaluation
Presence of comprehensive ADHD evaluation on chart
Documentation of a symptom scale at visit
Number of ADHD symptoms in HPI at last visit for ADHD
Scheduled a follow up ADHD visit within next 6 months

•
•
•
•
•
•
•

Receiving medications for ADHD at last visit
ADHD Medication type
Change in ADHD medication ever
Change in ADHD medication last 6 months
Change in ADHD medication current visit
Change in ADHD medication dose at current visit
ADHD Patient Education documented

Analysis(Plan
• Demographic Data: age, gender, race
– Assessment of normality

• Numeric variables: T-tests or appropriate
nonparametric tests (if assumptions not met)
– Means and standard deviations (T-tests)
– Medians and interquartile ranges (Nonparametric)

• Categorical Data:
– Frequencies and percent frequencies
– Chi-squared, possible Fishers’ exact test

14

  

  

  

102

FINAL DEFENSE
  
  

  

  
4/2/19

Resources(&(Cost
Doctor&of&Nursing&Practice&Project&Financial&Operating&Plan
Implementation&of&ASRS&for&adults&with&ADHD
Revenue
Project(Manager(Time((in1kind(donation)
Team(Member(Time:
Family(Physician(Project(Leader((site(mentor)
Registered(Nurse,(Practice(Manager
Family(Physician(Questionaire(time
Practice(Flow(Staff
Consultations
Statistician
ADHD(Expert
Cost(of(Space
TOTAL&INCOME
Expenses
Project(Manager(Time((in1kind(donation)
Team(Member(Time:
Family(Physician(Project(Leader((site(mentor)
Registered(Nurse,(Practice(Manager
Family(Physician(Questionaire(time
Practice(Flow(Staff
Consultations
Statistician
ADHD(Expert
Cost(of(Space
Cost(of(print/copy/fax
Laptop
TOTAL&EXPENSES
Net(Operating(Plan

10,500.00
2,790.00
150.00
349.00
145.00
435.00
250.00
800.00
15,419.00

• Providers time is
considered both revenue
and expense because
provides both
investment into the
project and also value
added to final project

10,500.00
2,790.00
150.00
349.00
145.00
435.00
250.00
800.00
40.00
1,000.00
16,459.00
11,040.00

Timeline
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Results

Results:(Participant(Characteristics

– Caucasian: 83%
– African American: 13%
– Other: 4%

• Age:
Pre or post intervention = pre

Pre or post intervention = post

40

30

Percent

• Gender:
– Female: 65%
– Male: 35%
• Race:

20

10

0
20

40

60

80

20

40

60

80

Age

*Normality assumption met across pre- and post- intervention groups
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Results:(Pre/Post(Education(Survey
Pre- or
PostImplemen
tation
Question 1: I would rate my knowledge of ADHD as
Pre______.
PostQuestion 2: I routinely use a validated symptom rating Prescale.
PostQuestion 3: I think a symptom scale is _____ helpful
Prein the management or treatment of ADHD.
PostQuestion 4: I know who to ask if I have a question
Preregarding ADHD management.
PostQuestion 5: My confidence in medication
Premanagement of an adult with ADHD is: _____.
PostQuestion 6: My understanding of medications and
Predosing for an adult with ADHD is:
PostQuestion 7: Documentation of ADHD symptoms and
Premanagement plan is easy.
PostQuestion 8: I routinely discuss nonpharmacological
Pretreatment options with my adult patients with ADHD. PostQuestion 9: I offer information on community
Preresources, support groups, or professional support to
Postadults with ADHD

Very low or Moderate/
low/ Never Sometimes
or rarely
3/9 (33%)
1/5 (20%)
6/9 (67%)
1/5 (20%)
1/9 (11%)
1/5 (20%)
1/9 (11%)
1/5 (20%)
2/9 (22%)
1/5 (20%)
2/9 (22%)
1/5 (20%)
2/9 (22%)
0/5 (0%)
0/9 (0%)
0/5 (0%)
3/9 (33%)
2/5 (40%)

4/9 (44%)
3/5 (60%)
2/9 (22%)
3/5 (60%)
4/9 (44%)
4/5 (80%)
1/9 (11%)
1/5 (20%)
4/9 (44%)
2/5 (40%)
5/9 (56%)
2/5 (40%)
4/9 (44%)
1/5 (20%)
4/9 (44%)
1/5 (20%)
3/9 (33%)
1/5 (20%)

High or
very high/
Usually or
always
2/9 (22%)
1/5 (20%)
1/9 (11%)
1/5 (20%)
4/9 (44%)
0/5 (0%)
7/8 (78%)
3/5 (60%)
3/9 (33%)
2/5 (40%)
2/9 (22%)
2/5 (40%)
3/9 (33%)
4/5 (80%)
5/9 (56%)
4/5 (80%)
3/9 (33%)
2/5 (40%)

Results:(Pre/Post(Education(Survey
• Provider Comments
– ASRS is helpful in “monitoring treatment response”
– “I worry rating scales (like pain scales + opioids) will
cause escalation of stimulant dosing”
– “Do we overuse stimulants for adults in the US. Is the
adult ADHD diagnosis accurate for my patient?”
– “better access to formal testing”
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Results:(Patient(Outcomes
• In this office, there
was no prior use of an
ADHD symptom scale.
• In the 5-week postimplementation period,
51% of providers used
the symptom scale at
the visit.

Use:of:ASRS:for:Adult:ADHD:patients
100%
90%
80%
70%
60%
50%
40%
30%
20%
10%
0%
Pre/implementation

Post/implementation

Results:(Patient(Outcomes
• Outcome measures found to be nonsignificant:
– Documenting a plan
– Scheduling a follow-up within 6 months
– Medication changes (dose or type)
– Documentation of ADHD education
– Diagnostic code frequency
– Number of ADHD symptoms in HPI

18
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Results:(Patient(Outcomes
• “Red Zone” or >5 inattentive or hyperactive
symptoms on ASRS
– 48% did not use the ASRS
– Of those that used the ASRS
• 57% had more than 5 clinically significant symptoms
• 43% had less than 5 clinically significant symptoms

Results:(Patient(Outcomes
• Medication Type
– 39% long-acting stimulant only
– 37% short-acting stimulant only
– 10% no medication
– 7% long-acting + short-acting stimulant
– 4% non-stimulant only
– 1% long-acting stimulant + non-stimulant
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Results:(Implementation(Strategy
• Plan-Do-Study-Act cycle 1
– 3 of 12 providers in the office
– Modification to the ASRS interpretation guide to
increase readability
– Modification of workflow instructions for support staff
– Creation of a transparent template for easy
identification of clinically significant symptoms
– Creation of ADHD Quality Improvement yellow
folders for providers and staff

Discussion
• Measurement-based care for mental health
– Increase precision and consistency in assessment,
tracking, and treatment

• Symptom rating scales supplement clinical
judgement
• Outcomes most improved:
– Symptom assessment correlates with clinical
encounter
– Occurs frequently
(Fortney et al., 2017)
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Discussion
• Project able to demonstrate improvement in use
of ASRS
– Unable to demonstrate significant outcomes or practice
change as a result of the use of the ASRS

• Areas for improvement in ADHD care in the
primary care setting
– Long-acting stimulants are considered first-line
therapy: best risk-benefit profile, effectiveness, and
duration
– 57% of adult patients had clinically significant
symptoms on the ASRS

Limitations
• Limited post-intervention provider survey responses
• Length of implementation and evaluation time
– Maximum benefit of measurement-based care expected
after repeated assessments

• ASRS not built into the electronic medical record
• Low volume of adult ADHD patients and many
appointment cancellations/no-shows
• Data collection
– Visit type coding and patients managed by outside practices

21
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Implications,for,Practice
Measurement-based care is considered standard of care
for ADHD and other psychiatric conditions
•
Most effective when used over time
•

Benefits: treatment fidelity, provider-patient
communication, patient engagement

Providers were able to adopt the use of a standardized
tool for a more comprehensive assessment of adult
ADHD

Conclusions
• Adult ADHD is a significant mental health
disorder
– Managed in primary care setting

• Measurement-based care
– Standard of practice
– Recommended by numerous guidelines
– Rarely used

• Implementation of ASRS and ADHD toolkit
– Began practice change
– Improved outcomes expected over time
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Sustainability+Plan
• Use of ASRS v1.1 will become easier as practice
is solidified
• Allows for ongoing symptom tracking which is
reinforcing
• Cost to sustain project is low
• ADHD toolkit and printed materials
• Site mentor is physician lead and could serve as
ADHD physician champion for the practice and
organization

Dissemination*
• Public presentation at GVSU final defense
• Findings presented to organizational
representative at final defense
• University database, ScholarWorks
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DNP$Essentials$Reflection
AACN Essential Competencies
• Scientific Underpinnings for Practice
– Literature review, chronic care model and model for
improvement

• Organizational and Systems Leadership
– Quality improvement project, organizational
assessment

• Clinical Scholarship and Analytical Methods
– Evidence-based project design and implementation

DNP$Essentials$Reflection
• Information Systems Technology
– Use of organizational EHR for data collection and
chart review

• Advocacy for Health Care Policy
– Organizational policy followed through IRB
proposal and approval process

• Interprofessional Collaboration
– Implementation of ASRS and adult ADHD toolkit
in primary care setting

24
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DNP$Essentials$Reflection
• Clinical Prevention and Population Health
– Analyzed data in the adult ADHD population to
identify practice gaps in care delivery

• Advanced Nursing Practice
– DNP student acted as a change agent to implement
the ASRS and adult ADHD toolkit in the primary
care setting
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